SOSUA BAY, Dominican Republic, Sept. 29, 2010 (GLOBE NEWSWIRE) -- Proton Laboratories, Inc. (Pink Sheets:PLBI - News) CEO, Armando Casciati, announced today that Dr. Lee has returned from training with RNL Bio Ltd. in Korea and stated, "The feedback we received from the training in South Korea was extremely positive and continues to reinforce our belief in the process of utilizing adult stem cells to reinvigorate the body and allow it to heal itself. Both Dr. Lee and his assistant had the opportunity to observe, document and study in detail the work being done by RNL directly and also saw U.S. cancer patients who had flown to Korea to be treated." RNL indicated it has had a number of potential patients contact them from the U.S.; however, the difficulty of such a long flight prevented them from going.
In addition, the clean lab modular system installation will commence on October 7th or 8th and is anticipated to take 3-4 weeks.
About Proton Laboratories, Inc. and its wholly owned subsidiary RegenoBody S.A:
RegenoBody S.A., a wholly owned subsidiary of Proton Laboratories, Inc., brings the benefits of bioscience to patients who have been diagnosed with chronic debilitating diseases, offering viable, efficient therapeutic options with special Stem Cell Therapies utilizing the most effective cell regeneration techniques. Therapies are tailored for each individual, based upon their specific needs. Cells are obtained by the most modern technological methods. The transplant physicians and stem cell laboratory scientists associated with RNL Bio have been regarded as some of the best in the world. Stem cells derived from Autologous (Stem cells taken from your own body) and Allogeneic (Stem cells from a source other than your own) are used depending on the particular condition that needs to be treated. Treatments will be delivered by an experienced team of International and U.S. Board Certified Physicians who are guided by strict protocols ensuring excellence in medical care.
About RNL Bio Company LTD:
RNL Bio is a premier biopharmaceutical company focused on development and commercialization of adult stem cell therapeutics and dog cloning technology. Headquartered in Seoul with a state-of-the-art GMP facility, RNL is a publicly traded company on the Korea Exchange (Code 003190) and strives to become a global leader across the biomedical industry.
FORWARD-LOOKING STATEMENT:
This report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this report are made as of the date hereof and the company undertakes no obligation to update such statements.
Wednesday, September 29, 2010
mBeach Software Inc. Focusing on End Results and Goal Achievements of First, Post Merger Milestone
TEL AVIV, Israel, Sept. 29, 2010 (GLOBE NEWSWIRE) -- mBeach Software Inc. ("MBHS") (OTCBB:MBHS - News), in accordance with company policy which recognizes the importance of regular communication and timely information delivered to investors, is committed to sharing with our stockholders regular updates on progress.
We have reached our first, post merger milestone and have assessed our goal achievements for the past four months.
mBeach's goals for the first milestone included redefining the activities of mBeach and Skin Cancer Scanning Ltd., instigating initial international marketing activities, progressing in the development of SkinScan 650, and strengthening and increasing shareholder value.
Redefining the core competence activities -- SCS is now focused on its core competencies of research and development, regulatory issues, and conducting further clinical trials in Israel. MBHS is focused on worldwide business and marketing activities. This restructuring will maximize companies' synergies.
Marketing activities -- mBeach has recently signed an MOU with a Russian company for initiating marketing activities in Russia and the Commonwealth of Independent States (CIS). We have identified the Japanese, Hi-Tech orientated market as a potential pivotal market, with increasing awareness to skin cancer related issues. We are now operating to initiate marketing steps into this market.
The U.S. market has been, since inception, the major target market and all development has been conducted in light of DFA and Reimbursement programs' requirements.
We expect these combined activities will increase and create stronger, long term, shareholder value.
About SCS
Skin Cancer Scanning Ltd. (SCS) is a medical device company pioneering the development and commercialization of a revolutionary and proprietary imaging system for the early detection and diagnosis of skin cancer.
Our product, SkinScan 650, is a non-invasive, point-of-care (in the doctor's office) system to detect and identify different kinds of skin nevi, tumors, lesions and cancers. SkinScan 650 enables physicians to diagnose skin cancer at an earlier, more curable stage. This will reduce the number of biopsies, lower treatment costs, and improve quality of life.
For more information on SCS, visit www.scs-med.com.
Forward Looking Statements
This release contains forward-looking statements, including, but not limited to, statements regarding the future commercialization of SCS' products, the market demand for these products and the proprietary protections the Company will obtain with regard to the technology, all of which statements are subject to market risks, and the possibility that the Company will not be able to obtain patent protection or obtain sufficient customer demand. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties.
We have reached our first, post merger milestone and have assessed our goal achievements for the past four months.
mBeach's goals for the first milestone included redefining the activities of mBeach and Skin Cancer Scanning Ltd., instigating initial international marketing activities, progressing in the development of SkinScan 650, and strengthening and increasing shareholder value.
Redefining the core competence activities -- SCS is now focused on its core competencies of research and development, regulatory issues, and conducting further clinical trials in Israel. MBHS is focused on worldwide business and marketing activities. This restructuring will maximize companies' synergies.
Marketing activities -- mBeach has recently signed an MOU with a Russian company for initiating marketing activities in Russia and the Commonwealth of Independent States (CIS). We have identified the Japanese, Hi-Tech orientated market as a potential pivotal market, with increasing awareness to skin cancer related issues. We are now operating to initiate marketing steps into this market.
The U.S. market has been, since inception, the major target market and all development has been conducted in light of DFA and Reimbursement programs' requirements.
We expect these combined activities will increase and create stronger, long term, shareholder value.
About SCS
Skin Cancer Scanning Ltd. (SCS) is a medical device company pioneering the development and commercialization of a revolutionary and proprietary imaging system for the early detection and diagnosis of skin cancer.
Our product, SkinScan 650, is a non-invasive, point-of-care (in the doctor's office) system to detect and identify different kinds of skin nevi, tumors, lesions and cancers. SkinScan 650 enables physicians to diagnose skin cancer at an earlier, more curable stage. This will reduce the number of biopsies, lower treatment costs, and improve quality of life.
For more information on SCS, visit www.scs-med.com.
Forward Looking Statements
This release contains forward-looking statements, including, but not limited to, statements regarding the future commercialization of SCS' products, the market demand for these products and the proprietary protections the Company will obtain with regard to the technology, all of which statements are subject to market risks, and the possibility that the Company will not be able to obtain patent protection or obtain sufficient customer demand. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties.
Assured Pharmacy Engages UHY, LLP As Auditors
FRISCO, Texas, Sept. 29 /PRNewswire/ -- Assured Pharmacy (Pink Sheets:APHY.pk - News), a pharmacy service healthcare organization operating a chain of specialty pharmacies providing advanced prescription medication fulfillment solutions to sufferers of chronic pain, is pleased to announce that it has retained UHY, LLP ("UHY") to serve as the Company's independent auditors. The decision to engage UHY was based on the Company's preference for a PCAOB accounting firm with national recognition and a strong regional presence that also has significant experience working with emerging growth companies.
"We are pleased to have engaged UHY as our independent auditors," said Robert DelVecchio, CEO of Assured Pharmacy. "We are working diligently towards having UHY complete an audit of our financial statements for the fiscal years ended December 31, 2009 and 2008. Going forward, our intention is to release our financial statements on a timely basis and have our annual financial statements audited. These actions are part of our plan to provide timely and accurate disclosure to our stockholders and further increase the transparency of our operations."
About Assured Pharmacy
Assured Pharmacy, Inc. is a growing chain of specialty pharmacies that provide advanced prescription services to a diverse array of medical professionals and their patients. Assured Pharmacy is committed to providing these physicians and patients with a better prescription process through four community locations. This enhanced process is achieved by blending our specialized service model with focused pharmacology. Our business model targets physicians specializing in pain management – anesthesiology, orthopedics, neurology, oncology, psychiatry, physical rehabilitation and industrial medicine. The focus is on treating patients with long-term, acute, chronic pain conditions.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. A wide variety of factors that may cause actual results to differ from the forward-looking statements include, but are not limited to, the following: the Company's ability to increase revenue and profits in the current economic climate; the effect of changing economic conditions; lack of sufficient financing for opening new pharmacies; inability to manage growth; and changes in government regulations, controls and similar matters. These cautionary statements should not be construed as exhaustive or as any admission as to the adequacy of the Company's disclosures. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes", "expects", "anticipates", "intends", "estimates", "plans", "projects", "should", or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. The Company does not undertake to publicly update or revise forward-looking statements, whether as a result of new information, future events or otherwise.
"We are pleased to have engaged UHY as our independent auditors," said Robert DelVecchio, CEO of Assured Pharmacy. "We are working diligently towards having UHY complete an audit of our financial statements for the fiscal years ended December 31, 2009 and 2008. Going forward, our intention is to release our financial statements on a timely basis and have our annual financial statements audited. These actions are part of our plan to provide timely and accurate disclosure to our stockholders and further increase the transparency of our operations."
About Assured Pharmacy
Assured Pharmacy, Inc. is a growing chain of specialty pharmacies that provide advanced prescription services to a diverse array of medical professionals and their patients. Assured Pharmacy is committed to providing these physicians and patients with a better prescription process through four community locations. This enhanced process is achieved by blending our specialized service model with focused pharmacology. Our business model targets physicians specializing in pain management – anesthesiology, orthopedics, neurology, oncology, psychiatry, physical rehabilitation and industrial medicine. The focus is on treating patients with long-term, acute, chronic pain conditions.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. A wide variety of factors that may cause actual results to differ from the forward-looking statements include, but are not limited to, the following: the Company's ability to increase revenue and profits in the current economic climate; the effect of changing economic conditions; lack of sufficient financing for opening new pharmacies; inability to manage growth; and changes in government regulations, controls and similar matters. These cautionary statements should not be construed as exhaustive or as any admission as to the adequacy of the Company's disclosures. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes", "expects", "anticipates", "intends", "estimates", "plans", "projects", "should", or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. The Company does not undertake to publicly update or revise forward-looking statements, whether as a result of new information, future events or otherwise.
Tuesday, September 28, 2010
Kalahari Greentech, Inc. Commences Testing of Wind Generator's Turbine Blades
BALTIMORE, Sept. 28, 2010 (GLOBE NEWSWIRE) -- Kalahari Greentech, Inc. (Pink Sheets:KHGT - News) released a statement today that company representatives have begun testing the Wind Generator's turbine blades. The test objectives will measure the total lift force generated by the airflow velocities, as well as the various angles of attack at various temperatures and relative humidity.
The data collected will be used to refine the configuration in the internal chambers of the wind generator, thus making the unit as effective and efficient as possible.
Wind and solar are fast becoming the leading sources of renewable energy, which puts Kalahari Greentech in the right place at the right time. Kalahari Greentech designs, produces and provides wind turbines, solar collectors and other sustainable energy technologies. Nearly $2 billion in money from the American Recovery and Reinvestment Act has been spent on wind power, funding the creation of enough new wind farms to power 2.4 million homes over the past year. (Source: www.abcnews.com).
In a Bloomberg Business Week article, General Electric Co. said it expects global industry-wide sales for land-based wind turbines to grow by $130 billion in the next two years. (Source: http://www.businessweek.com/news/2010-03-02/ge-sees-130-bln-jump-in-land-turbine-sales-by-2012-update1-.html).
Kalahari's Wind Generator concentrates wind energy in a manner such that it can generate electric power at speeds usually too slow for conventional wind generators to produce any meaningful energy, or to even operate. It can also be modified to operate in water. For instance, it can be utilized in streams, rivers and tidal basins.
More information can be found on the company's website, www.kalaharigt.com.
About Kalahari Greentech, Inc.: Kalahari Greentech Inc. is an energy company focused on developing, constructing and operating wind and solar energy projects, either on its own or in partnership with other energy companies. The company's main focus is to seek out opportunities to utilize its technology to develop renewable energy sources.
Forward Looking Statements: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.
The data collected will be used to refine the configuration in the internal chambers of the wind generator, thus making the unit as effective and efficient as possible.
Wind and solar are fast becoming the leading sources of renewable energy, which puts Kalahari Greentech in the right place at the right time. Kalahari Greentech designs, produces and provides wind turbines, solar collectors and other sustainable energy technologies. Nearly $2 billion in money from the American Recovery and Reinvestment Act has been spent on wind power, funding the creation of enough new wind farms to power 2.4 million homes over the past year. (Source: www.abcnews.com).
In a Bloomberg Business Week article, General Electric Co. said it expects global industry-wide sales for land-based wind turbines to grow by $130 billion in the next two years. (Source: http://www.businessweek.com/news/2010-03-02/ge-sees-130-bln-jump-in-land-turbine-sales-by-2012-update1-.html).
Kalahari's Wind Generator concentrates wind energy in a manner such that it can generate electric power at speeds usually too slow for conventional wind generators to produce any meaningful energy, or to even operate. It can also be modified to operate in water. For instance, it can be utilized in streams, rivers and tidal basins.
More information can be found on the company's website, www.kalaharigt.com.
About Kalahari Greentech, Inc.: Kalahari Greentech Inc. is an energy company focused on developing, constructing and operating wind and solar energy projects, either on its own or in partnership with other energy companies. The company's main focus is to seek out opportunities to utilize its technology to develop renewable energy sources.
Forward Looking Statements: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.
mBeach Software Inc. ("MBHS") Presses for Progress on Russian and CIS Market Penetration
TEL AVIV, Israel, Sept. 27, 2010 (GLOBE NEWSWIRE) -- mBeach Software Inc. ("MBHS") (OTCBB:MBHS - News): Following the August MOU with Russian company we are pressing for results from market penetration activities. To expedite the execution of mandatory procedures necessary for marketing approval in Russia, SCS, our wholly owned subsidiary, has forwarded all necessary information and technical support regarding SkinScan 650, our non-invasive, point-of-care system for the detection and identification of different types of skin cancers.
Russia and the CIS are among the fastest-growing healthcare markets globally. Total population of the region exceeds 270 million people, and there is increasing demand for advanced medical technologies. The health market opportunity is estimated at over $10 billion and forecast to grow at an impressive five-year compound average growth rate (CAGR) of 18.1% in US dollar terms.
According to health care experts, one of the most serious problems with cancer treatment in Russia is a very low rate of early detection. Typically, the disease is diagnosed at very advanced stages when treatment options are less effective and more costly.
These activities follow mBeach's recent announcement on the signing of an MOU for Russia and the Commonwealth of Independent States (CIS).
Completing these regulatory procedures will pave the way for local clinical trials and a full commercial launch of SkinScan 650. We expect to receive the initial approval by the end of November 2010.
About SCS
Skin Cancer Scanning Ltd. (SCS) is a medical device company pioneering the development of a revolutionary and proprietary imaging system for the early detection and diagnosis of skin cancer.
Our product, SkinScan 650, is a non-invasive, point-of-care (in the doctor's office) system to detect and identify different kinds of skin nevi, tumors, lesions and cancers. SkinScan 650 enables physicians to diagnose skin cancer at an earlier, more curable stage. This will reduce the number of biopsies, lower treatment costs, and improve quality of life.
For more information on SCS, visit www.scs-med.com.
Forward Looking Statements
This release contains forward-looking statements, including, but not limited to, statements regarding the future commercialization of SCS' products, the market demand for these products and the proprietary protections the Company will obtain with regard to the technology, all of which statements are subject to market risks, and the possibility that the Company will not be able to obtain patent protection or obtain sufficient customer demand. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties.
Russia and the CIS are among the fastest-growing healthcare markets globally. Total population of the region exceeds 270 million people, and there is increasing demand for advanced medical technologies. The health market opportunity is estimated at over $10 billion and forecast to grow at an impressive five-year compound average growth rate (CAGR) of 18.1% in US dollar terms.
According to health care experts, one of the most serious problems with cancer treatment in Russia is a very low rate of early detection. Typically, the disease is diagnosed at very advanced stages when treatment options are less effective and more costly.
These activities follow mBeach's recent announcement on the signing of an MOU for Russia and the Commonwealth of Independent States (CIS).
Completing these regulatory procedures will pave the way for local clinical trials and a full commercial launch of SkinScan 650. We expect to receive the initial approval by the end of November 2010.
About SCS
Skin Cancer Scanning Ltd. (SCS) is a medical device company pioneering the development of a revolutionary and proprietary imaging system for the early detection and diagnosis of skin cancer.
Our product, SkinScan 650, is a non-invasive, point-of-care (in the doctor's office) system to detect and identify different kinds of skin nevi, tumors, lesions and cancers. SkinScan 650 enables physicians to diagnose skin cancer at an earlier, more curable stage. This will reduce the number of biopsies, lower treatment costs, and improve quality of life.
For more information on SCS, visit www.scs-med.com.
Forward Looking Statements
This release contains forward-looking statements, including, but not limited to, statements regarding the future commercialization of SCS' products, the market demand for these products and the proprietary protections the Company will obtain with regard to the technology, all of which statements are subject to market risks, and the possibility that the Company will not be able to obtain patent protection or obtain sufficient customer demand. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties.
Genesis Electronics Bringing Reality to Technology From Johns Hopkins University Applied Physics Laboratory
HOLLYWOOD, FL--(Marketwire - 09/27/10) - Genesis Electronics Group, Inc. (OTC.BB:GEGI - News), www.genesiselectronicsgroup.com, a developer of solar-powered rechargeable battery modules for the Apple iPhone and iPod, the SunBlazer, is being showcased by Johns Hopkins University Applied Physics Laboratory (JHU/APL) in their upcoming INNOVATIONS Office of Technology Transfer Newsletter. The communication recognizes Genesis' creative use of their sophisticated technology and patent in the development of the solar powered product for consumers.
Below is the complete text of the newsletter from JHU/APL:
POWER PACKED
Infused with Johns Hopkins Applied Physics Laboratory Innovation, New Solar Charger Provides Energy on the Go
By Michael Buckley
In the mid-1990s, Johns Hopkins Applied Physics Laboratory researchers Joe Suter, Binh Le and Ark Lew had a clever idea for a small, thin, flexible device that can convert light to electricity.
They also had foresight and -- fortunately -- a bit of patience.
More than a decade later, their patented invention is close to reaching consumers. In late 2009, APL licensed the technology to Florida-based Genesis Electronics, which weaved APL's ideas into a sleek solar recharger called the SunBlazer's™. When attached to a cell phone or related electronic device, SunBlazer's™ 2- by 4-inch solar panel will continually draw energy from the Sun -- or any sufficient light source -- and keep the device charged.
"With its power and portability, the SunBlazer's™ is a true breakthrough in the recharging concept and an effective application of renewable energy," says Edward Dillon, CEO of Genesis Electronics Group.
Conceived primarily for use in satellites, APL's self-contained power circuit can fit a variety of applications and match the shape of the device it powers. Suter says that's why the inventors thought it also would have use in laptops or cell phones; yet they could only imagine the world of today, when practically everyone carries a cell phone, mobile computer or digital music player that all demand more and more power. "It was an invention before its time, before there was a market," Suter says. "So many people use these devices today, and they're looking for every bit of power they can find. The demand has caught up to our technology."
But Suter sees benefits beyond extra juice to run the latest apps and downloads. A quick jolt to a comatose phone battery might allow emergency calls from almost anywhere. Military readiness would get a boost from smaller, more efficient devices for powering GPS units, radios and countless other items soldiers carry that need a constant charge.
"APL researchers have the unique opportunity to deliver timely solutions to their sponsors and focus on the future applications of their technologies," says Kristin Gray, the Laboratory's Director of Technology Transfer. "In this case, they invented a solution to a problem that didn't even exist -- yet. That a technology devised in the 1990s could be relevant today tells you a lot about the insight and creativity that go into APL's cutting-edge work. And licensing these technologies to companies such as Genesis Electronics helps these innovative concepts to become reality."
Raymond F. Purdon, Genesis' Chairman of the Board, commented: "We are pleased to be working with Johns Hopkins University Applied Physics Laboratory and be in a position to apply their technology to the Genesis Electronics SunBlazer. There is a large demand for a cost effective solar powered battery charger for the iPhone and iPod. Genesis is intending to expand the relationship that we enjoy with JHU/APL for further research and development for future product development."
Genesis Electronics owns a solar-power source patent and has also secured the rights to two associated patents from Johns Hopkins University Applied Physics Laboratory.
For more information about the SunBlazer™ visit www.MySunblazer.com.
About Genesis Electronics, Inc.
Genesis Electronics, Inc. is a developmental stage electronics company with a patented process for charging and re-charging a battery from solar energy and efficiently transferring that energy to the battery of an electronic device. We have developed this technology to produce solar chargers for multi-featured cell phones, such as the G-2000 designed for the iPhone™. The key to Genesis Electronics' technology is its patented "Enhanced Solar to Battery Electronic Technology" for a unique process that charges a battery from solar energy and efficiently transfers that energy to the battery of an electronic device that optimizes the conversion of light into electrical energy. This technology can be applied to virtually any portable or hand-held electronic device.
Genesis Electronics, Inc. is a wholly-owned subsidiary of Genesis Electronics Group, Inc., a publicly traded corporation (symbol GEGI).
Forward Looking Statements
Except for historical matters, matters discussed in this release are forward-looking and are made pursuant to the safe harbor provisions of the 1995 Private Securities Litigation Reform Act. Investors are cautioned that these statements reflect numerous assumptions and involve risks and uncertainties that may affect Genesis Electronics Group, Inc., its business and prospects, and cause actual results to differ materially from these statements. Among these factors are Genesis Electronics Group, Inc.'s operations; competition; entry barriers; relationship reliance; technological changes; product demand; new systems introduction; vendors pricing; supply of software.
In light of risks and uncertainties in these forward-looking statements, they should not be regarded as a representation by Genesis Electronics Group, Inc. or any other person that the projected results, objectives or plans will be achieved. Genesis Electronics Group, Inc. undertakes no obligation to revise or update these statements to reflect events or circumstances after the date hereof.
Below is the complete text of the newsletter from JHU/APL:
POWER PACKED
Infused with Johns Hopkins Applied Physics Laboratory Innovation, New Solar Charger Provides Energy on the Go
By Michael Buckley
In the mid-1990s, Johns Hopkins Applied Physics Laboratory researchers Joe Suter, Binh Le and Ark Lew had a clever idea for a small, thin, flexible device that can convert light to electricity.
They also had foresight and -- fortunately -- a bit of patience.
More than a decade later, their patented invention is close to reaching consumers. In late 2009, APL licensed the technology to Florida-based Genesis Electronics, which weaved APL's ideas into a sleek solar recharger called the SunBlazer's™. When attached to a cell phone or related electronic device, SunBlazer's™ 2- by 4-inch solar panel will continually draw energy from the Sun -- or any sufficient light source -- and keep the device charged.
"With its power and portability, the SunBlazer's™ is a true breakthrough in the recharging concept and an effective application of renewable energy," says Edward Dillon, CEO of Genesis Electronics Group.
Conceived primarily for use in satellites, APL's self-contained power circuit can fit a variety of applications and match the shape of the device it powers. Suter says that's why the inventors thought it also would have use in laptops or cell phones; yet they could only imagine the world of today, when practically everyone carries a cell phone, mobile computer or digital music player that all demand more and more power. "It was an invention before its time, before there was a market," Suter says. "So many people use these devices today, and they're looking for every bit of power they can find. The demand has caught up to our technology."
But Suter sees benefits beyond extra juice to run the latest apps and downloads. A quick jolt to a comatose phone battery might allow emergency calls from almost anywhere. Military readiness would get a boost from smaller, more efficient devices for powering GPS units, radios and countless other items soldiers carry that need a constant charge.
"APL researchers have the unique opportunity to deliver timely solutions to their sponsors and focus on the future applications of their technologies," says Kristin Gray, the Laboratory's Director of Technology Transfer. "In this case, they invented a solution to a problem that didn't even exist -- yet. That a technology devised in the 1990s could be relevant today tells you a lot about the insight and creativity that go into APL's cutting-edge work. And licensing these technologies to companies such as Genesis Electronics helps these innovative concepts to become reality."
Raymond F. Purdon, Genesis' Chairman of the Board, commented: "We are pleased to be working with Johns Hopkins University Applied Physics Laboratory and be in a position to apply their technology to the Genesis Electronics SunBlazer. There is a large demand for a cost effective solar powered battery charger for the iPhone and iPod. Genesis is intending to expand the relationship that we enjoy with JHU/APL for further research and development for future product development."
Genesis Electronics owns a solar-power source patent and has also secured the rights to two associated patents from Johns Hopkins University Applied Physics Laboratory.
For more information about the SunBlazer™ visit www.MySunblazer.com.
About Genesis Electronics, Inc.
Genesis Electronics, Inc. is a developmental stage electronics company with a patented process for charging and re-charging a battery from solar energy and efficiently transferring that energy to the battery of an electronic device. We have developed this technology to produce solar chargers for multi-featured cell phones, such as the G-2000 designed for the iPhone™. The key to Genesis Electronics' technology is its patented "Enhanced Solar to Battery Electronic Technology" for a unique process that charges a battery from solar energy and efficiently transfers that energy to the battery of an electronic device that optimizes the conversion of light into electrical energy. This technology can be applied to virtually any portable or hand-held electronic device.
Genesis Electronics, Inc. is a wholly-owned subsidiary of Genesis Electronics Group, Inc., a publicly traded corporation (symbol GEGI).
Forward Looking Statements
Except for historical matters, matters discussed in this release are forward-looking and are made pursuant to the safe harbor provisions of the 1995 Private Securities Litigation Reform Act. Investors are cautioned that these statements reflect numerous assumptions and involve risks and uncertainties that may affect Genesis Electronics Group, Inc., its business and prospects, and cause actual results to differ materially from these statements. Among these factors are Genesis Electronics Group, Inc.'s operations; competition; entry barriers; relationship reliance; technological changes; product demand; new systems introduction; vendors pricing; supply of software.
In light of risks and uncertainties in these forward-looking statements, they should not be regarded as a representation by Genesis Electronics Group, Inc. or any other person that the projected results, objectives or plans will be achieved. Genesis Electronics Group, Inc. undertakes no obligation to revise or update these statements to reflect events or circumstances after the date hereof.
Thursday, September 23, 2010
U.S. Aerospace names Worsham CEO-industry sources
*Worsham is aerospace industry veteran
*Former CEO left as part of divestiture
WASHINGTON, Sept 23 (Reuters) - U.S. Aerospace Inc (USAE.OB), a Southern California-based aerospace contractor, has tapped industry veteran Jim Worsham as chief executive, industry sources said on Thursday.
Worsham, who previously held aerospace jobs with General Electric Co (GE.N) and the Douglas Aircraft unit of Boeing Co's (BA.N) McDonnell Douglas, has headed up aviation marketing and business development for the Southern California Logistics Airport for the last 10 years.
U.S. Aerospace announced earlier this month that its former chief executive, David Duquette, resigned that post as part of the divestiture of the company's machine-tool business [ID:nN15147827].
U.S. Aerospace attracted attention in July when it said it would partner with Antonov, the state-owned Ukrainian plane builder, to compete against Boeing and Airbus parent EADS (EAD.PA) for a multibillion-dollar contract to build a new generation of aerial refueling tankers for the U.S. military [ID:nN02192170].
In August, U.S. Aerospace filed a protest with the U.S. Government Accountability Office after its tanker proposal was rejected as late. (Reporting by Andrea Shalal-Esa, editing by Gerald E. McCormick)
*Former CEO left as part of divestiture
WASHINGTON, Sept 23 (Reuters) - U.S. Aerospace Inc (USAE.OB), a Southern California-based aerospace contractor, has tapped industry veteran Jim Worsham as chief executive, industry sources said on Thursday.
Worsham, who previously held aerospace jobs with General Electric Co (GE.N) and the Douglas Aircraft unit of Boeing Co's (BA.N) McDonnell Douglas, has headed up aviation marketing and business development for the Southern California Logistics Airport for the last 10 years.
U.S. Aerospace announced earlier this month that its former chief executive, David Duquette, resigned that post as part of the divestiture of the company's machine-tool business [ID:nN15147827].
U.S. Aerospace attracted attention in July when it said it would partner with Antonov, the state-owned Ukrainian plane builder, to compete against Boeing and Airbus parent EADS (EAD.PA) for a multibillion-dollar contract to build a new generation of aerial refueling tankers for the U.S. military [ID:nN02192170].
In August, U.S. Aerospace filed a protest with the U.S. Government Accountability Office after its tanker proposal was rejected as late. (Reporting by Andrea Shalal-Esa, editing by Gerald E. McCormick)
Wednesday, September 22, 2010
U.S. Aerospace, Inc. and AVIC International Holding Corporation Enter into Strategic Cooperation Agreement
LOS ANGELES--(BUSINESS WIRE)--U.S. Aerospace, Inc. (OTCBB: USAE), a U.S. aerospace and defense contractor, today announced that the Company has entered into a Strategic Cooperation Agreement with Supply Chain Management & Procurement of AVIC International Holding Corporation (AVIC) of China. The agreement sets forth a framework for collaborating in the manufacture, importing and exporting of aircraft components and equipment. It is anticipated that the parties will bid on at least US $100 million in potential orders in the first year.
Under the agreement, the Company will provide AVIC with potential projects on which the parties can jointly bid, or specifications for aircraft parts and components to be manufactured by AVIC for the Company or its customers. AVIC will supply all personnel, materials, facilities and other resources necessary to perform the work. Minimal annual delivery values are set through 2015.
In addition, the parties have agreed to negotiate in good faith to invest together in the United States, including the purchase of manufacturing facilities, and for AVIC to invest in the Company, including the potential purchase of USAE stock.
“Building long-term relationships with leading international aircraft manufacturers like AVIC greatly enhances our production and pricing capabilities,” commented Michael C. Cabral, President of U.S. Aerospace, Inc. “Partnering with AVIC advances our ability to bid for, secure and perform work we have previously turned away or did not pursue. Increased globalization and international cooperation will benefit both companies and all of their stakeholders.”
About AVIC International Holding Corporation
AVIC International Holding Corporation, based in Beijing, China, is a comprehensive multinational platform that owns 6 listed companies and 60 international offices with businesses in world aviation, commercial aircraft sales and service, international cooperation and subcontract production, global tendering and bidding, and many other areas. AVIC brings to bear the powerful manufacturing capabilities of the China aviation industry and over 30 years of aircraft manufacturing and sales experience. AVIC’s accumulated import and export trade volume exceeds US $40 billion.
About U.S. Aerospace, Inc.
U.S. Aerospace, Inc. is a publicly-traded aerospace and defense contractor based in Southern California. The Company is an emerging world-class supplier on projects for the Lockheed Martin Corporation (NYSE: LMT - News), L-3 Communications Holdings, Inc. (NYSE: LLL - News), the Middle River Aircraft Systems subsidiary of General Electric Company (NYSE: GE - News), and other aerospace companies, commercial aircraft manufacturers and prime defense contractors. The Company supplies aircraft assemblies, structural components and highly-engineered, precision-machined details for commercial and military aircraft. The Company has offices and production facilities in Rancho Cucamonga, California.
For further information please visit the Company’s website at http://www.USAerospace.com.
Forward Looking Statements
Except for statements of historical fact, the matters discussed above are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the Company's control, may cause actual results to differ materially from stated expectations. These risk factors include, among others, dependence on its key suppliers and international partners, limited capital resources, intense competition, government regulation, complications and risks related to bidding on government contracts, and difficulty in aerospace product and parts manufacturing; as well as additional risks factors discussed in the reports filed by the Company with the Securities and Exchange Commission, which are available on its website at http://www.sec.gov. Except as required by law, the Company undertakes no obligation to update any information.
Under the agreement, the Company will provide AVIC with potential projects on which the parties can jointly bid, or specifications for aircraft parts and components to be manufactured by AVIC for the Company or its customers. AVIC will supply all personnel, materials, facilities and other resources necessary to perform the work. Minimal annual delivery values are set through 2015.
In addition, the parties have agreed to negotiate in good faith to invest together in the United States, including the purchase of manufacturing facilities, and for AVIC to invest in the Company, including the potential purchase of USAE stock.
“Building long-term relationships with leading international aircraft manufacturers like AVIC greatly enhances our production and pricing capabilities,” commented Michael C. Cabral, President of U.S. Aerospace, Inc. “Partnering with AVIC advances our ability to bid for, secure and perform work we have previously turned away or did not pursue. Increased globalization and international cooperation will benefit both companies and all of their stakeholders.”
About AVIC International Holding Corporation
AVIC International Holding Corporation, based in Beijing, China, is a comprehensive multinational platform that owns 6 listed companies and 60 international offices with businesses in world aviation, commercial aircraft sales and service, international cooperation and subcontract production, global tendering and bidding, and many other areas. AVIC brings to bear the powerful manufacturing capabilities of the China aviation industry and over 30 years of aircraft manufacturing and sales experience. AVIC’s accumulated import and export trade volume exceeds US $40 billion.
About U.S. Aerospace, Inc.
U.S. Aerospace, Inc. is a publicly-traded aerospace and defense contractor based in Southern California. The Company is an emerging world-class supplier on projects for the Lockheed Martin Corporation (NYSE: LMT - News), L-3 Communications Holdings, Inc. (NYSE: LLL - News), the Middle River Aircraft Systems subsidiary of General Electric Company (NYSE: GE - News), and other aerospace companies, commercial aircraft manufacturers and prime defense contractors. The Company supplies aircraft assemblies, structural components and highly-engineered, precision-machined details for commercial and military aircraft. The Company has offices and production facilities in Rancho Cucamonga, California.
For further information please visit the Company’s website at http://www.USAerospace.com.
Forward Looking Statements
Except for statements of historical fact, the matters discussed above are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the Company's control, may cause actual results to differ materially from stated expectations. These risk factors include, among others, dependence on its key suppliers and international partners, limited capital resources, intense competition, government regulation, complications and risks related to bidding on government contracts, and difficulty in aerospace product and parts manufacturing; as well as additional risks factors discussed in the reports filed by the Company with the Securities and Exchange Commission, which are available on its website at http://www.sec.gov. Except as required by law, the Company undertakes no obligation to update any information.
PLBI Sends Dr. David Lee, a World Class Scientist, Together With an Associate MD to South Korea for Special Stem Cell Training, and Protocol Writing
SOSUA BAY, Dominican Republic, Sept. 21, 2010 (GLOBE NEWSWIRE) -- Proton Laboratories, Inc. (Pink Sheets:PLBI - News) CEO, Armando Casciati, announced today that Dr. Keunmyoung David Lee, Ph.D. will complete his training at RNL Bio Ltd. in Seoul South Korea this week. As part of the license agreement with RNL Bio that RegenoBody has, RNL Bio is obligated to provide training for designated personnel. Dr. Lee, who not only has an extensive background in stem cell research, but who also speaks fluent Korean, has spent the last week and will spend part of this week in training and educational instruction on the methodologies and techniques employed by RNL Bio in their laboratory as well as the systems and procedures they use in the cataloging and management of the stem cell cultures. Mr. Casciati went on to say that "with the completion of the training, coupled with the installation of the processing laboratory, our planned opening for business is making great progress. We are very gratified that we are now so close to meeting our planned objective of delivering world class services to needy patients."
Dr. Keunmyoung David Lee, Ph.D. is a widely published and respected research scientist with expertise in the areas of biochemistry, molecular biology and cell biology with a particular focus on Mesenchymal Stem Cell research. He has over 25 years of biotechnology lab experience, including 10 years experience in managing biotechnology company operations. Dr. Lee was critical in the initial laboratory setup and ongoing management of the company where he has worked over the past 8 years. Prior to that, Dr. Lee assisted in launching Rexahn Corporation and served as Director of Discovery Program, initiating and managing R&D in various areas including anti-cancer, anti-viral, bioinformatics and computational biology. Given these positions, along with previous roles he has served--as Senior Scientist at Osiris Therapeutics and as a Post Doctoral Fellow at Case Western Reserve University--Dr. Lee is recognized as one of the leading experts in the most cutting-edge areas of gene therapy, tissue generation and cancer research, specifically with respect to the use of Mesenchymal Stem Cells.
Dr. Lee received his Ph.D. in Genetics at University of California, Riverside, M.S. in Biochemistry at Emory University and B.S. in Chemistry and Education in Seoul National University. He is a member of various professional science and research associations, including NIH CounterACT Network Research Symposium, American Society of Gene Therapy and The Society of Biomedical Research. Dr. Lee has been widely published in peer-reviewed journals and publications, and has delivered numerous scientific orations and seminars, on topics within the scope of gene therapy and cancer research, most notably on his research and publications on Mesenchymal Stem Cells.
About Proton Laboratories, Inc. and its wholly owned subsidiary RegenoBody S.A: RegenoBody S.A., a wholly owned subsidiary of Proton Laboratories, Inc., brings the benefits of bioscience to patients who have been diagnosed with chronic debilitating diseases, offering viable, efficient therapeutic options with special Stem Cell Therapies utilizing the most effective adult stem cells in the world today. Therapies are tailored for each individual, based upon their specific needs. Cells are obtained by the most modern technologic methods. The transplant physicians and stem cell laboratory scientists, associated with RNL Bio have been regarded as some of the best in the world. Stem cells derived from Autologous (Stem cells taken from your own body) and Allogeneic (Stem cells from a source other than your own) are used depending on the particular condition that needs to be treated. Treatments will be delivered by an experienced team of International and U.S. Board Certified Physicians who are guided by strict protocols ensuring excellence in medical care.
About RNL Bio Company LTD:
RNL Bio is a premier biopharmaceutical company focused on development and commercialization of adult stem cell therapeutics and dog cloning technology. Headquartered in Seoul with state-of-the-art GMP facility, RNL is publicly traded company on the Korea Exchange (Code 003190) and strives to become a global leader across the biomedical industry.
FORWARD-LOOKING STATEMENT:
This report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this report are made as of the date hereof and the company undertakes no obligation to update such statements.
Dr. Keunmyoung David Lee, Ph.D. is a widely published and respected research scientist with expertise in the areas of biochemistry, molecular biology and cell biology with a particular focus on Mesenchymal Stem Cell research. He has over 25 years of biotechnology lab experience, including 10 years experience in managing biotechnology company operations. Dr. Lee was critical in the initial laboratory setup and ongoing management of the company where he has worked over the past 8 years. Prior to that, Dr. Lee assisted in launching Rexahn Corporation and served as Director of Discovery Program, initiating and managing R&D in various areas including anti-cancer, anti-viral, bioinformatics and computational biology. Given these positions, along with previous roles he has served--as Senior Scientist at Osiris Therapeutics and as a Post Doctoral Fellow at Case Western Reserve University--Dr. Lee is recognized as one of the leading experts in the most cutting-edge areas of gene therapy, tissue generation and cancer research, specifically with respect to the use of Mesenchymal Stem Cells.
Dr. Lee received his Ph.D. in Genetics at University of California, Riverside, M.S. in Biochemistry at Emory University and B.S. in Chemistry and Education in Seoul National University. He is a member of various professional science and research associations, including NIH CounterACT Network Research Symposium, American Society of Gene Therapy and The Society of Biomedical Research. Dr. Lee has been widely published in peer-reviewed journals and publications, and has delivered numerous scientific orations and seminars, on topics within the scope of gene therapy and cancer research, most notably on his research and publications on Mesenchymal Stem Cells.
About Proton Laboratories, Inc. and its wholly owned subsidiary RegenoBody S.A: RegenoBody S.A., a wholly owned subsidiary of Proton Laboratories, Inc., brings the benefits of bioscience to patients who have been diagnosed with chronic debilitating diseases, offering viable, efficient therapeutic options with special Stem Cell Therapies utilizing the most effective adult stem cells in the world today. Therapies are tailored for each individual, based upon their specific needs. Cells are obtained by the most modern technologic methods. The transplant physicians and stem cell laboratory scientists, associated with RNL Bio have been regarded as some of the best in the world. Stem cells derived from Autologous (Stem cells taken from your own body) and Allogeneic (Stem cells from a source other than your own) are used depending on the particular condition that needs to be treated. Treatments will be delivered by an experienced team of International and U.S. Board Certified Physicians who are guided by strict protocols ensuring excellence in medical care.
About RNL Bio Company LTD:
RNL Bio is a premier biopharmaceutical company focused on development and commercialization of adult stem cell therapeutics and dog cloning technology. Headquartered in Seoul with state-of-the-art GMP facility, RNL is publicly traded company on the Korea Exchange (Code 003190) and strives to become a global leader across the biomedical industry.
FORWARD-LOOKING STATEMENT:
This report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this report are made as of the date hereof and the company undertakes no obligation to update such statements.
Tuesday, September 21, 2010
Proton Laboratories, Inc./RegenoBody Announces Delivery of Lab to Sosua Site
SOSUA BAY, Dominican Republic, Sept. 20, 2010 (GLOBE NEWSWIRE) -- Proton Laboratories, Inc. (Pink Sheets:PLBI - News) CEO, Armando Casciati, announced today that the clean lab modular system has been released from customs and delivered to the laboratory site across the street from the clinic in a standalone facility. "We expect the lab to be installed and the remaining two pieces of equipment to be delivered by the end of October," stated Mr. Casciati. Mr. Casciati went on to say that "we are taking every precaution to construct this laboratory to the standards needed to safeguard the process of stem cell regeneration and with the supervision of Dr. Lee, we are confident that it will be done properly. Once a patient's fatty tissue stem cells are removed and analyzed, the lab will be the key factor in the regeneration of new stem cells from clients and therefore must be processed in a very clean, secure environment with detailed record keeping and culture identification. The lab will also be the key in new research and development projects that may be presented.
About Proton Laboratories, Inc. and its wholly owned subsidiary RegenoBody S.A:
RegenoBody S.A., a wholly owned subsidiary of Proton Laboratories, Inc., brings the benefits of bioscience to patients who have been diagnosed with chronic debilitating diseases, offering viable, efficient therapeutic options with special Stem Cell Therapies utilizing the most effective cell regeneration techniques. Therapies are tailored for each individual, based upon their specific needs. Cells are obtained by the most modern technologic methods. The transplant physicians and stem cell laboratory scientists, associated with RNL Bio have been regarded as some of the best in the world. Stem cells derived from Autologous (Stem cells taken from your own body) and Allogeneic (Stem cells from a source other than your own) are used depending on the particular condition that needs to be treated. Treatments will be delivered by an experienced team of International and U.S. Board Certified Physicians who are guided by strict protocols ensuring excellence in medical care.
About RNL Bio Company LTD:
RNL Bio is a premier biopharmaceutical company focused on development and commercialization of adult stem cell therapeutics and dog cloning technology. Headquartered in Seoul with state-of-the-art GMP facility, RNL is publicly traded company on the Korea Exchange (Code 003190) and strives to become a global leader across the biomedical industry.
FORWARD-LOOKING STATEMENT:
This report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this report are made as of the date hereof and the company undertakes no obligation to update such statements.
About Proton Laboratories, Inc. and its wholly owned subsidiary RegenoBody S.A:
RegenoBody S.A., a wholly owned subsidiary of Proton Laboratories, Inc., brings the benefits of bioscience to patients who have been diagnosed with chronic debilitating diseases, offering viable, efficient therapeutic options with special Stem Cell Therapies utilizing the most effective cell regeneration techniques. Therapies are tailored for each individual, based upon their specific needs. Cells are obtained by the most modern technologic methods. The transplant physicians and stem cell laboratory scientists, associated with RNL Bio have been regarded as some of the best in the world. Stem cells derived from Autologous (Stem cells taken from your own body) and Allogeneic (Stem cells from a source other than your own) are used depending on the particular condition that needs to be treated. Treatments will be delivered by an experienced team of International and U.S. Board Certified Physicians who are guided by strict protocols ensuring excellence in medical care.
About RNL Bio Company LTD:
RNL Bio is a premier biopharmaceutical company focused on development and commercialization of adult stem cell therapeutics and dog cloning technology. Headquartered in Seoul with state-of-the-art GMP facility, RNL is publicly traded company on the Korea Exchange (Code 003190) and strives to become a global leader across the biomedical industry.
FORWARD-LOOKING STATEMENT:
This report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this report are made as of the date hereof and the company undertakes no obligation to update such statements.
Thursday, September 16, 2010
Assured Pharmacy Reports Same Store Sales for the Month of August 2010
FRISCO, Texas, Sept. 16 /PRNewswire-FirstCall/ -- Assured Pharmacy (Pink Sheets:APHY.pk - News), a leading specialty pharmacy group providing prescription medications to more than 3,000 sufferers of chronic pain announced that total sales on a same store basis for the month of August 2010 were $1,423,819 which equates to $64,719 per business day. It represents an increase of 24.1 percent when compared with total sales of $1,147,398 for August 2009. This also represents an increase of 0.1 percent compared with total sales of $1,422,163 for July 2010 and a decrease of 4.4 percent compared with total sales per business day of $67,722 for July 2010.
Our total sales for the last three "summer" months combined (June – August) were $4,248,356 which represents a 10.8 percent increase over total sales of $3,832,962 for the previous three month period (March – May).
"We are very pleased to exit our historically slower summer months with much stronger sales than when we entered. We are also excited to announce that we achieved the 3,000 monthly patient milestone for the first time with a total of 3,030 patients serviced during the month of August," said Robert DelVecchio, Chief Executive Officer of Assured Pharmacy. "As these sales figures reflect, we remain on track for increased sales and market share growth, improved earnings at the store level and stronger cash flow."
About Assured Pharmacy, Inc.
Assured Pharmacy, Inc. is engaged in the business of operating specialty pharmacies that primarily dispense highly regulated pain medication. The Company derives its revenue primarily from the sale of prescription drugs and does not keep in inventory non-prescription drugs or health and beauty related products inventoried at traditional pharmacies. The Company offers physicians the ability to electronically transmit prescriptions to its pharmacies. The majority of the Company's business is derived from repeat business from its customers. "Walk-in" prescriptions from physicians are limited. The Company currently has four operating pharmacies. Three of those pharmacies are wholly owned and the Company has a 94.8% ownership interest in the other pharmacy.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. A wide variety of factors that may cause actual results to differ from the forward-looking statements include, but are not limited to, the following: the Company's ability to increase revenue and profits in the current economic climate; the effect of changing economic conditions; lack of sufficient financing for opening new pharmacies; inability to manage growth; and changes in government regulations, controls and similar matters. These cautionary statements should not be construed as exhaustive or as any admission as to the adequacy of the Company's disclosures. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes," "expects," "anticipates," "intends," "estimates," "plans," "projects," "should," or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. The Company does not undertake to publicly update or revise forward-looking statements, whether as a result of new information, future events or otherwise.
Our total sales for the last three "summer" months combined (June – August) were $4,248,356 which represents a 10.8 percent increase over total sales of $3,832,962 for the previous three month period (March – May).
"We are very pleased to exit our historically slower summer months with much stronger sales than when we entered. We are also excited to announce that we achieved the 3,000 monthly patient milestone for the first time with a total of 3,030 patients serviced during the month of August," said Robert DelVecchio, Chief Executive Officer of Assured Pharmacy. "As these sales figures reflect, we remain on track for increased sales and market share growth, improved earnings at the store level and stronger cash flow."
About Assured Pharmacy, Inc.
Assured Pharmacy, Inc. is engaged in the business of operating specialty pharmacies that primarily dispense highly regulated pain medication. The Company derives its revenue primarily from the sale of prescription drugs and does not keep in inventory non-prescription drugs or health and beauty related products inventoried at traditional pharmacies. The Company offers physicians the ability to electronically transmit prescriptions to its pharmacies. The majority of the Company's business is derived from repeat business from its customers. "Walk-in" prescriptions from physicians are limited. The Company currently has four operating pharmacies. Three of those pharmacies are wholly owned and the Company has a 94.8% ownership interest in the other pharmacy.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. A wide variety of factors that may cause actual results to differ from the forward-looking statements include, but are not limited to, the following: the Company's ability to increase revenue and profits in the current economic climate; the effect of changing economic conditions; lack of sufficient financing for opening new pharmacies; inability to manage growth; and changes in government regulations, controls and similar matters. These cautionary statements should not be construed as exhaustive or as any admission as to the adequacy of the Company's disclosures. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes," "expects," "anticipates," "intends," "estimates," "plans," "projects," "should," or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. The Company does not undertake to publicly update or revise forward-looking statements, whether as a result of new information, future events or otherwise.
Wednesday, September 15, 2010
Sunvalley Solar Provides Revenue Outlook; Forecasts Double-Digit Revenue Growth
WALNUT, Calif., Sept. 15 /PRNewswire/ -- Sunvalley Solar, Inc. (OTC Bulletin Board:SSOL.ob - News), a leading solar power technology and solar system integration company, today announces its revenue outlook for 2010 and 2011.
For 2010, Sunvalley Solar forecasts revenue in the range of $5.5 million to $6.0 million. That would be an increase of 25% to 36% over 2009's net sales of $4.4 million, reflecting the continued strong demand for their solar power solutions.
For 2011, Sunvalley Solar anticipates revenue in the range of $8.0 million to $10.0 million. That would be an increase of 39% to 73% over the midpoint guidance forecast for 2010. The increase is attributed to recently announced commercial solar installation contracts as well as a strong sales pipeline.
"We continue to see strong increasing demand for our solar power system solutions and expect that both 2010 and 2011 will be record revenue years," said James Zhang, CEO of Sunvalley Solar. "With our well-established partnerships with leading manufacturers such as Canadian Solar Inc., CEEG SST, TianWei Solarfilms and PV Powered we will provide solar system solutions with extraordinary quality at tremendously competitive prices to our customers."
About Sunvalley Solar Inc.
Sunvalley Solar, Inc. is a leading solar system solution provider that offers comprehensive solar energy technology, system design, installation, equipment, and technical support for electrical contractors, builders, homeowners, businesses/commercial buildings, and government entities. Clients are assisted in lowering utility bills, reducing environmental impact, and increasing energy reliability and independence through solar energy. Located in Los Angeles, California, Sunvalley Solar, Inc. is committed to reducing the world's carbon footprint by offering alternatives to traditional energy sources in the form of renewable energy resources such as solar - the nation's mainstream source of renewable power.
To learn more, visit www.sunvalleysolarinc.com.
Forward-Looking Statement: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from acquisitions or actions in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this document may also contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those contained in such statements. Such risks, uncertainties, and factors include, but are not limited to, future capital needs, changes, and delays in product development plans and schedules, or market acceptance.
For 2010, Sunvalley Solar forecasts revenue in the range of $5.5 million to $6.0 million. That would be an increase of 25% to 36% over 2009's net sales of $4.4 million, reflecting the continued strong demand for their solar power solutions.
For 2011, Sunvalley Solar anticipates revenue in the range of $8.0 million to $10.0 million. That would be an increase of 39% to 73% over the midpoint guidance forecast for 2010. The increase is attributed to recently announced commercial solar installation contracts as well as a strong sales pipeline.
"We continue to see strong increasing demand for our solar power system solutions and expect that both 2010 and 2011 will be record revenue years," said James Zhang, CEO of Sunvalley Solar. "With our well-established partnerships with leading manufacturers such as Canadian Solar Inc., CEEG SST, TianWei Solarfilms and PV Powered we will provide solar system solutions with extraordinary quality at tremendously competitive prices to our customers."
About Sunvalley Solar Inc.
Sunvalley Solar, Inc. is a leading solar system solution provider that offers comprehensive solar energy technology, system design, installation, equipment, and technical support for electrical contractors, builders, homeowners, businesses/commercial buildings, and government entities. Clients are assisted in lowering utility bills, reducing environmental impact, and increasing energy reliability and independence through solar energy. Located in Los Angeles, California, Sunvalley Solar, Inc. is committed to reducing the world's carbon footprint by offering alternatives to traditional energy sources in the form of renewable energy resources such as solar - the nation's mainstream source of renewable power.
To learn more, visit www.sunvalleysolarinc.com.
Forward-Looking Statement: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from acquisitions or actions in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this document may also contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those contained in such statements. Such risks, uncertainties, and factors include, but are not limited to, future capital needs, changes, and delays in product development plans and schedules, or market acceptance.
Tuesday, September 14, 2010
Sunvalley Solar Rescinds Equity Financing Agreement
WALNUT, Calif., Sept. 14 /PRNewswire-FirstCall/ -- Sunvalley Solar, Inc. (OTC Bulletin Board:SSOL.ob - News), a leading provider of solar power technology and solar system integration company, announced that, after careful review and deliberation, its Board of Directors has decided to rescind its Drawdown Equity Financing Agreement ("DEFA") and an accompanying Registration Rights Agreement with Auctus Private Equity Fund, LLC, a Massachusetts limited liability company.
The Board of Director's has determined that it would not be in the company's best interest to move forward with the equity line. Sunvalley Solar has not issued or sold any shares to Auctus under the DEFA nor has an S1 Registration statement been filed.
About Sunvalley Solar, Inc.
Sunvalley Solar, Inc. is a leading solar system solution provider that offers comprehensive solar energy technology, system design, installation, equipments, and technical support for electrical contractors, builders, homeowners, businesses/commercial buildings, and government entities that assist them in lowering of utility bills, reducing environmental impacts, and increasing energy reliability and independence through solar energy. Located in Los Angeles, California, Sunvalley Solar, Inc. is committed to reducing the world's carbon foot print from traditional energy sources to make renewable sources such as solar the nation's mainstream source of power.
To learn more, visit www.sunvalleysolarinc.com.
Forward-Looking Statement: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from acquisitions or actions in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this document may also contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those contained in such statements. Such risks, uncertainties, and factors include, but are not limited to, future capital needs, changes, and delays in product development plans and schedules, or market acceptance.
The Board of Director's has determined that it would not be in the company's best interest to move forward with the equity line. Sunvalley Solar has not issued or sold any shares to Auctus under the DEFA nor has an S1 Registration statement been filed.
About Sunvalley Solar, Inc.
Sunvalley Solar, Inc. is a leading solar system solution provider that offers comprehensive solar energy technology, system design, installation, equipments, and technical support for electrical contractors, builders, homeowners, businesses/commercial buildings, and government entities that assist them in lowering of utility bills, reducing environmental impacts, and increasing energy reliability and independence through solar energy. Located in Los Angeles, California, Sunvalley Solar, Inc. is committed to reducing the world's carbon foot print from traditional energy sources to make renewable sources such as solar the nation's mainstream source of power.
To learn more, visit www.sunvalleysolarinc.com.
Forward-Looking Statement: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from acquisitions or actions in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this document may also contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those contained in such statements. Such risks, uncertainties, and factors include, but are not limited to, future capital needs, changes, and delays in product development plans and schedules, or market acceptance.
AMFE Technology Now Integrated Across All Sectors of Food and Beverage Industry
SAN LUIS OBISPO, CA--(Marketwire - 09/14/10) - AMFIL Technologies, Inc. (Pinksheets:AMFE - News), integrator of ozone-based cleaning and antimicrobial systems for the food and beverage industry, is pleased to report the Company's ozone technologies and applications have now been integrated into the broadest areas of the food and beverage industries, including meat, seafood, fruits and vegetables, beverage bottling, aquaculture, and animal husbandry.
AMFIL's customers include Arrowhead Water, PepsiCo, Sun Pacific Produce, Fresh Water Fish Corporation, Sysco Food Service, San Diego Zoo, and PescaNova Seafood.
AMFIL is the most capable company to engineer and integrate its ozone technology for safe and efficacious operation. This competence is based on the company's over 25 years of food plant engineering, operations, and quality assurance experience, in addition to over 10 years of ozone system engineering, science, sales, and marketing experience. AMFIL takes on a true integrator role, teaming with the client through the entire process of technology demonstration, efficacy validation, pilot system design, and finally full system integration.
Ambrose Fillis, President and CEO of AMFIL Technologies, states, "This is an exciting time for our company. Our non-chemical based antimicrobial ozone systems are now available for use in all sectors of the food and beverage industry. We anticipate orders directly to AMFIL Technologies to rise worldwide due to increased government regulations and demand for environmentally-friendly, cold water ozone-powered cleaning and antimicrobial systems."
For more information, please contact Investor Relations at (973) 351-3868 or visit the company website directly: www.amfiltech.com.
About AMFIL Technologies, Inc.:
AMFIL is the manufacturer of cold water ozone-powered cleaning and antimicrobial systems for food/food processing equipment, zoological life support facilities/fish farming, and gaseous ozone fumigation systems for produce cold storage and transport. AMFIL's products include the mobile mPact-5 and mPact-10 systems, the mPact-25, mPact-45S, mPact-250S, and mPact-500S centralized systems, mPact-CSF cold storage fumigation system, and mPact-RCF refrigerated container fumigation system. In addition, AMFIL manufactures the mPact-CAS, a system designed specifically for cased meat log cleaning & antimicrobial treatment.
Safe Harbor
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.
The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.
AMFIL's customers include Arrowhead Water, PepsiCo, Sun Pacific Produce, Fresh Water Fish Corporation, Sysco Food Service, San Diego Zoo, and PescaNova Seafood.
AMFIL is the most capable company to engineer and integrate its ozone technology for safe and efficacious operation. This competence is based on the company's over 25 years of food plant engineering, operations, and quality assurance experience, in addition to over 10 years of ozone system engineering, science, sales, and marketing experience. AMFIL takes on a true integrator role, teaming with the client through the entire process of technology demonstration, efficacy validation, pilot system design, and finally full system integration.
Ambrose Fillis, President and CEO of AMFIL Technologies, states, "This is an exciting time for our company. Our non-chemical based antimicrobial ozone systems are now available for use in all sectors of the food and beverage industry. We anticipate orders directly to AMFIL Technologies to rise worldwide due to increased government regulations and demand for environmentally-friendly, cold water ozone-powered cleaning and antimicrobial systems."
For more information, please contact Investor Relations at (973) 351-3868 or visit the company website directly: www.amfiltech.com.
About AMFIL Technologies, Inc.:
AMFIL is the manufacturer of cold water ozone-powered cleaning and antimicrobial systems for food/food processing equipment, zoological life support facilities/fish farming, and gaseous ozone fumigation systems for produce cold storage and transport. AMFIL's products include the mobile mPact-5 and mPact-10 systems, the mPact-25, mPact-45S, mPact-250S, and mPact-500S centralized systems, mPact-CSF cold storage fumigation system, and mPact-RCF refrigerated container fumigation system. In addition, AMFIL manufactures the mPact-CAS, a system designed specifically for cased meat log cleaning & antimicrobial treatment.
Safe Harbor
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.
The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.
Assured Pharmacy Receives $500,000 in Debt Financing
FRISCO, Texas, Sept. 14 /PRNewswire-FirstCall/ -- Assured Pharmacy (Pink Sheets:APHY.pk - News), a pharmacy service healthcare organization operating a chain of specialty pharmacies providing advanced prescription medication fulfillment solutions to sufferers of chronic pain, is pleased to announce that it has received $500,000 of debt financing from an existing shareholder which can be converted in whole or in part anytime over the 2 year term at the holder's option into a maximum of 500 shares of the Company's Series A Preferred Stock. Interest on the debt, which is payable in shares of the Company's Common Stock, accrues on the unconverted principal amount outstanding from time to time at the rate of ten percent (10%) per annum and is payable to the holder on a quarterly basis and on the maturity date, which is July 20, 2012.
This financing is supporting the Company's ongoing business expansion and investment into solidifying its supply chain of prescription medications. "We believe that this investment from our existing shareholder validates their confidence in our business model and supports our corporate actions enacted over the past 18 months," stated Mr. Robert DelVecchio, Chief Executive Officer of Assured Pharmacy. "We are very pleased to have the support of this investment as we enter the next phase of our business model. As we lay the foundation for expanding our pharmacy footprint into new markets, improving our financial position with suppliers is critical and this financing furthers that requirement. We expect to provide further updates shortly and are pleased to have secured this financing arrangement in an economic cycle which proves difficult to secure funds on favorable terms."
About Assured Pharmacy
Assured Pharmacy, Inc. is a growing chain of specialty pharmacies that provide advanced prescription services to a diverse array of medical professionals and their patients. Assured Pharmacy is committed to providing these physicians and patients with a better prescription process through four community locations. This enhanced process is achieved by blending our specialized service model with focused pharmacology. Our business model targets physicians specializing in pain management – anesthesiology, orthopedics, neurology, oncology, psychiatry, physical rehabilitation and industrial medicine. The focus is on treating patients with long-term, acute, chronic pain conditions.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. A wide variety of factors that may cause actual results to differ from the forward-looking statements include, but are not limited to, the following: the Company's ability to increase revenue and profits in the current economic climate; the effect of changing economic conditions; lack of sufficient financing for opening new pharmacies; inability to manage growth; and changes in government regulations, controls and similar matters. These cautionary statements should not be construed as exhaustive or as any admission as to the adequacy of the Company's disclosures. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes", "expects", "anticipates", "intends", "estimates", "plans", "projects", "should", or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. The Company does not undertake to publicly update or revise forward-looking statements, whether as a result of new information, future events or otherwise.
This financing is supporting the Company's ongoing business expansion and investment into solidifying its supply chain of prescription medications. "We believe that this investment from our existing shareholder validates their confidence in our business model and supports our corporate actions enacted over the past 18 months," stated Mr. Robert DelVecchio, Chief Executive Officer of Assured Pharmacy. "We are very pleased to have the support of this investment as we enter the next phase of our business model. As we lay the foundation for expanding our pharmacy footprint into new markets, improving our financial position with suppliers is critical and this financing furthers that requirement. We expect to provide further updates shortly and are pleased to have secured this financing arrangement in an economic cycle which proves difficult to secure funds on favorable terms."
About Assured Pharmacy
Assured Pharmacy, Inc. is a growing chain of specialty pharmacies that provide advanced prescription services to a diverse array of medical professionals and their patients. Assured Pharmacy is committed to providing these physicians and patients with a better prescription process through four community locations. This enhanced process is achieved by blending our specialized service model with focused pharmacology. Our business model targets physicians specializing in pain management – anesthesiology, orthopedics, neurology, oncology, psychiatry, physical rehabilitation and industrial medicine. The focus is on treating patients with long-term, acute, chronic pain conditions.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. A wide variety of factors that may cause actual results to differ from the forward-looking statements include, but are not limited to, the following: the Company's ability to increase revenue and profits in the current economic climate; the effect of changing economic conditions; lack of sufficient financing for opening new pharmacies; inability to manage growth; and changes in government regulations, controls and similar matters. These cautionary statements should not be construed as exhaustive or as any admission as to the adequacy of the Company's disclosures. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes", "expects", "anticipates", "intends", "estimates", "plans", "projects", "should", or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. The Company does not undertake to publicly update or revise forward-looking statements, whether as a result of new information, future events or otherwise.
Sunvalley Solar Signs Partnership Agreement With TianWei SolarFilms
WALNUT, Calif., Sept. 13 /PRNewswire/ -- Sunvalley Solar, Inc. (OTC Bulletin Board:SSOL.ob - News), a leading solar power technology and solar system integration company, announces a partnership agreement with TianWei SolarFilms, a solar thin film supplier in China.
Baoding TianWei SolarFilms Co., Ltd. is a subsidiary company of Baoding TianWei Group Co., Ltd. As the leading company in China's power transformer industry and as one of the biggest companies in the power transformer industry, TianWei Group has also made great performance in photovoltaic industry and become the only company in China with core products and services substantially covering the entire PV industry value from ingots, wafers, PV cells, modules manufacturing to PV system design and installation. TianWei SolarFilms is now one of the world's leading suppliers in the solar market. On July 1st, 2010, TianWei SolarFilms was successful in having their a-Si thin film product listed with the CEC (California Energy Committee), thus making them eligible to supply PV modules to the U.S.
Sunvalley Solar, with this strategic partnership, will add the TianWei thin film products to an already impressive product offering which includes Canadian Solar's poly and mono crystalline panels, CEEG's high efficiency mono crystalline panels and solar inverters from PV Powered. All of these strategic alliances enable Sunvalley Solar to supply complete solar systems from concept to installation at highly competitive prices.
"TianWei Group has taken a leading role in facilitating the Clean Energy Revolution by providing its high efficiency thin film solar panels," said James Zhang, CEO of Sunvalley Solar. "We look forward to a long-term relationship with TianWei SolarFilms, and know this partnership will contribute to the bottom line and dramatically enhance our product offering."
About TianWei SolarFilms
Baoding TianWei SolarFilms Co., Ltd. is a globalized high-tech company, which specializes in designing, manufacturing, selling and installing thin film solar modules and related accessories. Located in the National Renewable Energy & Equipment Industry Base in China, TianWei boasts both an internationally recognized R&D team and an extremely experienced management group. TianWei SolarFilms has invested approximately 1.2 billion RMB for phase 1 of their production plan to reach 50 MW and will have the capacity to reach 500 MW by 2015. To learn more, visit TianWei SolarFilms at http://www.btw-solarfilms.com
About Sunvalley Solar, Inc.
Sunvalley Solar, Inc. is a leading solar system solution provider that offers comprehensive solar energy technology, system design, installation, equipments, and technical support for electrical contractors, builders, homeowners, businesses/commercial buildings, and government entities that assist them in lowering utility bills, reducing environmental impacts, and increasing energy reliability and independence through solar energy. Located in Los Angeles, California, Sunvalley Solar, Inc. is committed to reducing the world's carbon foot print from traditional energy sources to make renewable sources such as solar the nation's mainstream source of power.
Baoding TianWei SolarFilms Co., Ltd. is a subsidiary company of Baoding TianWei Group Co., Ltd. As the leading company in China's power transformer industry and as one of the biggest companies in the power transformer industry, TianWei Group has also made great performance in photovoltaic industry and become the only company in China with core products and services substantially covering the entire PV industry value from ingots, wafers, PV cells, modules manufacturing to PV system design and installation. TianWei SolarFilms is now one of the world's leading suppliers in the solar market. On July 1st, 2010, TianWei SolarFilms was successful in having their a-Si thin film product listed with the CEC (California Energy Committee), thus making them eligible to supply PV modules to the U.S.
Sunvalley Solar, with this strategic partnership, will add the TianWei thin film products to an already impressive product offering which includes Canadian Solar's poly and mono crystalline panels, CEEG's high efficiency mono crystalline panels and solar inverters from PV Powered. All of these strategic alliances enable Sunvalley Solar to supply complete solar systems from concept to installation at highly competitive prices.
"TianWei Group has taken a leading role in facilitating the Clean Energy Revolution by providing its high efficiency thin film solar panels," said James Zhang, CEO of Sunvalley Solar. "We look forward to a long-term relationship with TianWei SolarFilms, and know this partnership will contribute to the bottom line and dramatically enhance our product offering."
About TianWei SolarFilms
Baoding TianWei SolarFilms Co., Ltd. is a globalized high-tech company, which specializes in designing, manufacturing, selling and installing thin film solar modules and related accessories. Located in the National Renewable Energy & Equipment Industry Base in China, TianWei boasts both an internationally recognized R&D team and an extremely experienced management group. TianWei SolarFilms has invested approximately 1.2 billion RMB for phase 1 of their production plan to reach 50 MW and will have the capacity to reach 500 MW by 2015. To learn more, visit TianWei SolarFilms at http://www.btw-solarfilms.com
About Sunvalley Solar, Inc.
Sunvalley Solar, Inc. is a leading solar system solution provider that offers comprehensive solar energy technology, system design, installation, equipments, and technical support for electrical contractors, builders, homeowners, businesses/commercial buildings, and government entities that assist them in lowering utility bills, reducing environmental impacts, and increasing energy reliability and independence through solar energy. Located in Los Angeles, California, Sunvalley Solar, Inc. is committed to reducing the world's carbon foot print from traditional energy sources to make renewable sources such as solar the nation's mainstream source of power.
Kalahari Greentech, Inc. Throws Its Bid Into the Fast-Growing Wind Energy Industry With Its Refined Wind Generator
BALTIMORE, Sept. 13, 2010 (GLOBE NEWSWIRE) -- Kalahari Greentech, Inc. (Pink Sheets:KHGT - News) released a statement today that the company is close to completing the modeling of turbine surfaces for its Wind Generator product. Kalahari's Wind Generator concentrates wind energy in a manner such that it can generate electric power at speeds usually too slow for conventional wind generators to produce any meaningful energy.
Despite a crippling recession and tight credit markets, the American wind power industry grew at a blistering pace in 2009, adding 39 percent more capacity. The country is close to the point where 2 percent of its electricity will come from wind turbines. (Source: http://www.nytimes.com/2010/01/26/business/energy-environment/26wind.html.)
"The U.S. wind industry shattered all installation records in 2009, and this was directly attributable to the lifeline that was provided by the stimulus package," said Denise Bode, the trade association's chief executive. "About as much new power-generating capacity came from wind as from natural gas last year," Ms. Bode said. Since 2002, the country's installed base of wind turbines has jumped almost sevenfold.
The American Wind Energy Association, in its annual report said the amount of capacity added last year, 9,900 megawatts, was the largest on record, and was 18 percent above the capacity added in 2008, also a banner year.
"It is not a question of lack of resources," said Tim Stephure, an analyst at Emerging Energy Research, a consulting firm in Cambridge, Mass. "Unlike the federal highway system or the national gas system, there is a huge lack of federal oversight for electricity. This is something that will take time, while the need for the industry is now." Still, the potential for wind is enormous. Mr. Stephure said that by 2020, wind's installed capacity could be five times higher than it is today, reaching about 180,000 megawatts.
Chief Engineer, Robert Matthews, states, "The results of the test confirm the design objectives, creating a turbine air surface that will operate in sub 10 mph (16 kph) wind conditions. By also utilizing thermal currents available in many installations, Kalahari is creating a device that operates well in environments with low sustained wind speeds. Once the wind speed increases beyond 10mph, the generator will convert into a vertical-axis wind turbine mode, providing maximum efficiency over a wide range of wind speed."
Most wind turbines start operating at a speed of 4-5 metres per second [9-11 mph] and reach maximum power at about 15 m/s [34 mph]. (Source: http://www.bwea.com [RenewableUK]).
The effect of the Kalahari wind generator is to create a mode of operation at wind speeds lower than what is currently available. Typical front-facing windmills have a lift to drag ratio of 60 to 1. The test results revealed that the lift to drag ratio for the Wind Generator was 157.8 to 1 at a two degree angle of attack. In fact, the lift to drag ratio remained over 100 to 1 from 0 to 8 degree angles of attack. Collection chamber testing showed a wind concentration of 2 to 1 with no blowback or turbulence.
Wind and solar are fast becoming the leading sources of renewable energy, which puts Kalahari Greentech in the right place at the right time. Kalahari Greentech designs wind turbines, solar collectors and other sustainable energy technologies. Nearly $2 billion in money from the American Recovery and Reinvestment Act has been spent on wind power, funding the creation of enough new wind farms to power 2.4 million homes over the past year. (Source: www.abcnews.com).
More information can be found on the company's website, www.kalaharigt.com.
About Kalahari Greentech, Inc.: Kalahari Greentech Inc. is an energy company focused on developing, constructing and operating wind and solar energy projects, either on its own or in partnership with other energy companies. The company's main focus is to seek out opportunities to utilize its technology to develop renewable energy sources.
Forward Looking Statements: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.
Despite a crippling recession and tight credit markets, the American wind power industry grew at a blistering pace in 2009, adding 39 percent more capacity. The country is close to the point where 2 percent of its electricity will come from wind turbines. (Source: http://www.nytimes.com/2010/01/26/business/energy-environment/26wind.html.)
"The U.S. wind industry shattered all installation records in 2009, and this was directly attributable to the lifeline that was provided by the stimulus package," said Denise Bode, the trade association's chief executive. "About as much new power-generating capacity came from wind as from natural gas last year," Ms. Bode said. Since 2002, the country's installed base of wind turbines has jumped almost sevenfold.
The American Wind Energy Association, in its annual report said the amount of capacity added last year, 9,900 megawatts, was the largest on record, and was 18 percent above the capacity added in 2008, also a banner year.
"It is not a question of lack of resources," said Tim Stephure, an analyst at Emerging Energy Research, a consulting firm in Cambridge, Mass. "Unlike the federal highway system or the national gas system, there is a huge lack of federal oversight for electricity. This is something that will take time, while the need for the industry is now." Still, the potential for wind is enormous. Mr. Stephure said that by 2020, wind's installed capacity could be five times higher than it is today, reaching about 180,000 megawatts.
Chief Engineer, Robert Matthews, states, "The results of the test confirm the design objectives, creating a turbine air surface that will operate in sub 10 mph (16 kph) wind conditions. By also utilizing thermal currents available in many installations, Kalahari is creating a device that operates well in environments with low sustained wind speeds. Once the wind speed increases beyond 10mph, the generator will convert into a vertical-axis wind turbine mode, providing maximum efficiency over a wide range of wind speed."
Most wind turbines start operating at a speed of 4-5 metres per second [9-11 mph] and reach maximum power at about 15 m/s [34 mph]. (Source: http://www.bwea.com [RenewableUK]).
The effect of the Kalahari wind generator is to create a mode of operation at wind speeds lower than what is currently available. Typical front-facing windmills have a lift to drag ratio of 60 to 1. The test results revealed that the lift to drag ratio for the Wind Generator was 157.8 to 1 at a two degree angle of attack. In fact, the lift to drag ratio remained over 100 to 1 from 0 to 8 degree angles of attack. Collection chamber testing showed a wind concentration of 2 to 1 with no blowback or turbulence.
Wind and solar are fast becoming the leading sources of renewable energy, which puts Kalahari Greentech in the right place at the right time. Kalahari Greentech designs wind turbines, solar collectors and other sustainable energy technologies. Nearly $2 billion in money from the American Recovery and Reinvestment Act has been spent on wind power, funding the creation of enough new wind farms to power 2.4 million homes over the past year. (Source: www.abcnews.com).
More information can be found on the company's website, www.kalaharigt.com.
About Kalahari Greentech, Inc.: Kalahari Greentech Inc. is an energy company focused on developing, constructing and operating wind and solar energy projects, either on its own or in partnership with other energy companies. The company's main focus is to seek out opportunities to utilize its technology to develop renewable energy sources.
Forward Looking Statements: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.
Sunday, September 12, 2010
Sunvalley Solar Completes Installation of Solar System in Arcadia, California
WALNUT, Calif., Sept. 10 /PRNewswire/ -- Sunvalley Solar, Inc. (OTC Bulletin Board:SSOL.ob - News), a leading solar power technology and solar system integration company, announces the completion and full operation of a 20,520W solar system in Arcadia, California.
The solar system, designed and installed by Sunvalley, provides approximately 20,520W of clean electric power to the commercial end user. The array consists of 72 pieces of SST285-72M CEEG SST mono-crystalline PV modules mounted on racks and four PV Powered 3 phase inverters, and a PV Powered data-monitoring package. The data, displayed on a large LCD monitor, allows the general public to view solar energy being generated and consumed.
"Sunvalley, in promoting its Green Community Program across the greater Los Angeles area, helps clients decrease both their cost for electricity and their carbon footprint. This project represents an excellent start for our Green Community Program. We believe that making energy choices that are good for the environment goes hand-in-hand with improving the lives of those living in our communities," said James Zhang, CEO of Sunvalley Solar, Inc.
About Sunvalley Solar, Inc.
Sunvalley Solar, Inc. is a leading solar system solution provider that offers comprehensive solar energy technology, system design, installation, equipments, and technical support for electrical contractors, builders, homeowners, businesses/commercial buildings, and government entities that assist them in the lowering of utility bills, reducing environmental impacts, and increasing energy reliability and independence through solar energy. Located in Los Angeles, California, Sunvalley Solar, Inc. is committed to reducing the world's carbon foot print from traditional energy sources to make renewable sources, such as solar, the nation's mainstream source of power.
To learn more, visit www.sunvalleysolarinc.com.
Forward-Looking Statement: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from acquisitions or actions in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this document may also contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those contained in such statements. Such risks, uncertainties, and factors include, but are not limited to, future capital needs, changes, and delays in product development plans and schedules, or market acceptance.
The solar system, designed and installed by Sunvalley, provides approximately 20,520W of clean electric power to the commercial end user. The array consists of 72 pieces of SST285-72M CEEG SST mono-crystalline PV modules mounted on racks and four PV Powered 3 phase inverters, and a PV Powered data-monitoring package. The data, displayed on a large LCD monitor, allows the general public to view solar energy being generated and consumed.
"Sunvalley, in promoting its Green Community Program across the greater Los Angeles area, helps clients decrease both their cost for electricity and their carbon footprint. This project represents an excellent start for our Green Community Program. We believe that making energy choices that are good for the environment goes hand-in-hand with improving the lives of those living in our communities," said James Zhang, CEO of Sunvalley Solar, Inc.
About Sunvalley Solar, Inc.
Sunvalley Solar, Inc. is a leading solar system solution provider that offers comprehensive solar energy technology, system design, installation, equipments, and technical support for electrical contractors, builders, homeowners, businesses/commercial buildings, and government entities that assist them in the lowering of utility bills, reducing environmental impacts, and increasing energy reliability and independence through solar energy. Located in Los Angeles, California, Sunvalley Solar, Inc. is committed to reducing the world's carbon foot print from traditional energy sources to make renewable sources, such as solar, the nation's mainstream source of power.
To learn more, visit www.sunvalleysolarinc.com.
Forward-Looking Statement: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from acquisitions or actions in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this document may also contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those contained in such statements. Such risks, uncertainties, and factors include, but are not limited to, future capital needs, changes, and delays in product development plans and schedules, or market acceptance.
Thursday, September 9, 2010
Truesport Alliances & Entertainment, Ltd.'s TapouT R&D Training Center Breaks Membership Record
LAS VEGAS, Sept. 9, 2010 (GLOBE NEWSWIRE) -- Truesport Alliances & Entertainment, Ltd.'s (OTCPK:TSAN) TapouT R&D Training Center has exceeded its previous records for membership sales. Despite current economy challenges and summer month heat, the TapouT R&D Training Center located at 4040 W. Hacienda Ave., Las Vegas, NV 89118 has experienced a major growth in memberships.
As the first standalone of its kind, the TapouT R&D Training Center is predominately a class based fitness facility with a full schedule that features a spectrum of MMA themed training. In addition to a broad selection of martial arts instruction, the majority of the cardio/fitness classes are non-contact.
"The TapouT R&D Training Center is the first of its kind and offers best experience for our members. Here, you can train with the pro's and like the pro's at any fitness level with today's leading MMA equipment that we manufacture," said Scott Ence, President of Truesport Alliances & Entertainment, Ltd.
Amateur and professional fighters will have the opportunity to train with TapouT Certified Instructors. Classes or private sessions will be available with some of the world's most decorated instructors. Additionally, the TapouT Training Center will offer children's classes available for all ages.
"We have a strong sense of family at the TapouT R&D Training Centers. Our members know that our service is to them by providing the best coaches and trainers in the industry," said Kekoa Quipotla, partner at the TapouT R&D Training Center.
For more information, see www.tapoutlasvegas.com or call 702-838-2582 702-838-2582.
About Truesport Alliances & Entertainment, Ltd.
Truesport Alliances & Entertainment, Ltd. is a premier logistic marketer of branded concepts and equipment, partnering with the mixed martial arts (MMA) industry leaders. Embedded with the explosive growth MMA sport, the company's current clientele base includes the industry's top brands such as UFC, TapouT, Strikeforce and Gold's Gym. Visit the Truesport Alliances, Ltd. website at www.truesportltd.com.
As the first standalone of its kind, the TapouT R&D Training Center is predominately a class based fitness facility with a full schedule that features a spectrum of MMA themed training. In addition to a broad selection of martial arts instruction, the majority of the cardio/fitness classes are non-contact.
"The TapouT R&D Training Center is the first of its kind and offers best experience for our members. Here, you can train with the pro's and like the pro's at any fitness level with today's leading MMA equipment that we manufacture," said Scott Ence, President of Truesport Alliances & Entertainment, Ltd.
Amateur and professional fighters will have the opportunity to train with TapouT Certified Instructors. Classes or private sessions will be available with some of the world's most decorated instructors. Additionally, the TapouT Training Center will offer children's classes available for all ages.
"We have a strong sense of family at the TapouT R&D Training Centers. Our members know that our service is to them by providing the best coaches and trainers in the industry," said Kekoa Quipotla, partner at the TapouT R&D Training Center.
For more information, see www.tapoutlasvegas.com or call 702-838-2582 702-838-2582.
About Truesport Alliances & Entertainment, Ltd.
Truesport Alliances & Entertainment, Ltd. is a premier logistic marketer of branded concepts and equipment, partnering with the mixed martial arts (MMA) industry leaders. Embedded with the explosive growth MMA sport, the company's current clientele base includes the industry's top brands such as UFC, TapouT, Strikeforce and Gold's Gym. Visit the Truesport Alliances, Ltd. website at www.truesportltd.com.
Kalahari Greentech, Inc. Details Wind Generation Growth Forecasts
BALTIMORE, Sept. 9, 2010 (GLOBE NEWSWIRE) -- Kalahari Greentech, Inc. (Pink Sheets:KHGT - News) released a statement today that according to EIA's International Energy Outlook 2010, wind generation is expected to account for more than 3% of total world electricity by 2020 (Source: http://www.eia.doe.gov/energy_in_brief/wind_power.cfm?src=email).
Wind and solar are fast becoming the leading sources of renewable energy, which puts Kalahari Greentech in the right place at the right time. Kalahari Greentech designs, produces and provides wind turbines, solar collectors and other sustainable energy technologies. Nearly $2 billion in money from the American Recovery and Reinvestment Act has been spent on wind power, funding the creation of enough new wind farms to power 2.4 million homes over the past year. (Source: www.abcnews.com).
Kalahari's Wind Generator concentrates wind energy in a manner such that it can generate electric power at speeds usually too slow for conventional wind generators to produce any meaningful energy, or to even operate.
Many wind generators on the market today are a hazard to birds and other wildlife. Kalahari's Wind Generator avoids the bird strike problem because each unit comes standard with a shield that blocks birds from being hit by the turbine blades.
The 2009 World Wind Energy Report issued by the World Wind Energy Association illustrated impressive growth rates in the wind sector in 2009, despite the global financial crisis. The report states, "Increasing awareness of the economic, social and environmental benefits of wind energy will further boost investment in new wind farms." (Source: www.wwindea.org).
More information can be found on the company's website, www.kalaharigt.com.
About Kalahari Greentech, Inc.: Kalahari Greentech Inc. is an energy company focused on developing, constructing and operating wind and solar energy projects, either on its own or in partnership with other energy companies. The company's main focus is to seek out opportunities to utilize its technology to develop renewable energy sources.
Forward Looking Statements: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.
Wind and solar are fast becoming the leading sources of renewable energy, which puts Kalahari Greentech in the right place at the right time. Kalahari Greentech designs, produces and provides wind turbines, solar collectors and other sustainable energy technologies. Nearly $2 billion in money from the American Recovery and Reinvestment Act has been spent on wind power, funding the creation of enough new wind farms to power 2.4 million homes over the past year. (Source: www.abcnews.com).
Kalahari's Wind Generator concentrates wind energy in a manner such that it can generate electric power at speeds usually too slow for conventional wind generators to produce any meaningful energy, or to even operate.
Many wind generators on the market today are a hazard to birds and other wildlife. Kalahari's Wind Generator avoids the bird strike problem because each unit comes standard with a shield that blocks birds from being hit by the turbine blades.
The 2009 World Wind Energy Report issued by the World Wind Energy Association illustrated impressive growth rates in the wind sector in 2009, despite the global financial crisis. The report states, "Increasing awareness of the economic, social and environmental benefits of wind energy will further boost investment in new wind farms." (Source: www.wwindea.org).
More information can be found on the company's website, www.kalaharigt.com.
About Kalahari Greentech, Inc.: Kalahari Greentech Inc. is an energy company focused on developing, constructing and operating wind and solar energy projects, either on its own or in partnership with other energy companies. The company's main focus is to seek out opportunities to utilize its technology to develop renewable energy sources.
Forward Looking Statements: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.
Wednesday, September 8, 2010
Truesport Alliances & Entertainment, Ltd. Awarded International Contract for Event Logistics
New Contract Awarded for Brazilian MMA Event
LAS VEGAS, Sept. 8, 2010 (GLOBE NEWSWIRE) -- Truesport Alliances & Entertainment, Ltd. (Pink Sheets:TSAN - News) has been awarded a contract for event logistics in next month's premiere mixed martial arts (MMA) promotion in Brazil. Included in this contract will be layout and design of the cage canvas from Truesport Alliances & Entertainment, Ltd.'s renowned graphics team. This custom canvas will be used for a promotional commercial to be aired on broadcast television and social networks.
"No other MMA company has designed as many custom cage canvases as Truesport. Our team has done work for literally every major MMA promotion that has been seen on pay-per-view, commercial and broadcast television," said Scott Ence, President of Truesport Alliances & Entertainment, Ltd.
The Truesport Alliances & Entertainment, Ltd. custom designs cage canvases with hi-definition printing on the company's own digi-canvas. Truesport Alliances & Entertainment, Ltd.'s event logistic team offers a turnkey solution for everything from cage rental, custom cage branding, layout and design of cage and ring canvas, coordinating with sponsors and graphics, setup and tear down of MMA equipment and equipment management during the fight.
For more information, see www.truesportltd.com.
About Truesport Alliances & Entertainment, Ltd.
Truesport Alliances & Entertainment, Ltd. is the premier logistic marketer of branded concepts and equipment, partnering with the mixed martial arts (MMA) industry leaders. Embedded with the explosive growth MMA sport, the company's current clientele base includes the industry's top brands such as UFC, TapouT, Strikeforce and Gold's Gym. Visit the Truesport Alliances, Ltd. website at www.truesportltd.com.
LAS VEGAS, Sept. 8, 2010 (GLOBE NEWSWIRE) -- Truesport Alliances & Entertainment, Ltd. (Pink Sheets:TSAN - News) has been awarded a contract for event logistics in next month's premiere mixed martial arts (MMA) promotion in Brazil. Included in this contract will be layout and design of the cage canvas from Truesport Alliances & Entertainment, Ltd.'s renowned graphics team. This custom canvas will be used for a promotional commercial to be aired on broadcast television and social networks.
"No other MMA company has designed as many custom cage canvases as Truesport. Our team has done work for literally every major MMA promotion that has been seen on pay-per-view, commercial and broadcast television," said Scott Ence, President of Truesport Alliances & Entertainment, Ltd.
The Truesport Alliances & Entertainment, Ltd. custom designs cage canvases with hi-definition printing on the company's own digi-canvas. Truesport Alliances & Entertainment, Ltd.'s event logistic team offers a turnkey solution for everything from cage rental, custom cage branding, layout and design of cage and ring canvas, coordinating with sponsors and graphics, setup and tear down of MMA equipment and equipment management during the fight.
For more information, see www.truesportltd.com.
About Truesport Alliances & Entertainment, Ltd.
Truesport Alliances & Entertainment, Ltd. is the premier logistic marketer of branded concepts and equipment, partnering with the mixed martial arts (MMA) industry leaders. Embedded with the explosive growth MMA sport, the company's current clientele base includes the industry's top brands such as UFC, TapouT, Strikeforce and Gold's Gym. Visit the Truesport Alliances, Ltd. website at www.truesportltd.com.
mBeach Software Inc. Restructuring
TEL AVIV, Israel, Sept. 8, 2010 (GLOBE NEWSWIRE) -- mBeach Software Inc. ("MBHS") (OTCBB:MBHS - News) announced today plans to redefine the activities of MBHS and Skin Cancer Scanning Ltd. (SCS). This follows the July 15 announcement of the closure of the merger with SCS, as a result of which MBHS holds 100% of SCS.
This new plan defines how each company will focus on its core competence activities, with the goal of maximizing synergies, and creating stronger shareholder value.
Under the new plan, SCS will focus on its core competencies of research and development, regulatory issues, and conducting further clinical trials in Israel. MBHS will focus on worldwide business and marketing activities.
The former management of MBHS has been entirely replaced by a new management, including members of the former SCS management. The new team combines leading scientific and technical experts as well as international marketing experience and expertise.
Col. Yossi Biderman, MBHS's new CEO, stated, "We feel this new restructuring of mBeach and SCS will best leverage the core competencies of each company. This follows our strategy to increase synergies between the companies and grow total shareholder value. We believe this move will strengthen the company and enable us to succeed in the global market for advanced technologies to better detect skin cancers."
About SCS
Skin Cancer Scanning Ltd. (SCS) is a medical device company pioneering the development and commercialization of a revolutionary and proprietary imaging system for the early detection and diagnosis of skin cancer.
Our product, SkinScan 650, is a non-invasive, point-of-care (in the doctor's office) system to detect and identify different kinds of skin nevi, tumors, lesions and cancers. SkinScan 650 enables physicians to diagnose skin cancer at an earlier, more curable stage. This will reduce the number of biopsies, lower treatment costs, and improve quality of life.
For more information on SCS, visit www.scs-med.com.
Forward Looking Statements
This release contains forward-looking statements, including, but not limited to, statements regarding the future commercialization of SCS products, the market demand for these products and the proprietary protections the Company will obtain with regard to the technology, all of which statements are subject to market risks, and the possibility that the Company will not be able to obtain patent protection or obtain sufficient customer demand. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties.
This new plan defines how each company will focus on its core competence activities, with the goal of maximizing synergies, and creating stronger shareholder value.
Under the new plan, SCS will focus on its core competencies of research and development, regulatory issues, and conducting further clinical trials in Israel. MBHS will focus on worldwide business and marketing activities.
The former management of MBHS has been entirely replaced by a new management, including members of the former SCS management. The new team combines leading scientific and technical experts as well as international marketing experience and expertise.
Col. Yossi Biderman, MBHS's new CEO, stated, "We feel this new restructuring of mBeach and SCS will best leverage the core competencies of each company. This follows our strategy to increase synergies between the companies and grow total shareholder value. We believe this move will strengthen the company and enable us to succeed in the global market for advanced technologies to better detect skin cancers."
About SCS
Skin Cancer Scanning Ltd. (SCS) is a medical device company pioneering the development and commercialization of a revolutionary and proprietary imaging system for the early detection and diagnosis of skin cancer.
Our product, SkinScan 650, is a non-invasive, point-of-care (in the doctor's office) system to detect and identify different kinds of skin nevi, tumors, lesions and cancers. SkinScan 650 enables physicians to diagnose skin cancer at an earlier, more curable stage. This will reduce the number of biopsies, lower treatment costs, and improve quality of life.
For more information on SCS, visit www.scs-med.com.
Forward Looking Statements
This release contains forward-looking statements, including, but not limited to, statements regarding the future commercialization of SCS products, the market demand for these products and the proprietary protections the Company will obtain with regard to the technology, all of which statements are subject to market risks, and the possibility that the Company will not be able to obtain patent protection or obtain sufficient customer demand. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties.
Convenience TV Announces Agreement With MediaRich Marketing of Los Angeles
LOS ANGELES, CA--(Marketwire - 09/08/10) - Convenience TV Inc. (OTC.BB:CRPZ - News) is pleased to announce that Los Angeles-based marketing firm and consultancy firm MediaRich Marketing has signed on to work with Convenience TV Inc. in the development of advertising, promotions, product placement and sponsorships for the digital network.
President and CEO Norman Knowles states, "MediaRich is a good fit with their knowledge of the LA and national markets as well as their product placement and retail experience."
MediaRich Marketing works with television networks, syndicated television shows and digital networks to develop strategies to help generate revenue and drive sales. Convenience TV is a digital programming network which provides content in convenience stores based initially in the Los Angeles, California metro area with plans to extend to the top 20 advertising markets in the USA over the next several years.
MediaRich Marketing President Rick Thomas says, "The increase in digital signage in and around retail locations continues to grow quickly and The C Store Network is poised to provide convenience stores with content and sales related programs to help increase retail sales, which is much needed during this current economic environment. With brands looking for ways to extend their reach well beyond traditional methods of advertising, digital networks like C Store are perfect outlets to achieve those goals."
MediaRich Marketing has worked with ABC Television, Sum of the Best Productions, NASCAR Angels, Midas, CruisePoints.com and set up major product integration opportunities on game shows, talk shows and reality shows.
Safe Harbor Statement
Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to Convenience TV or its management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors such as the level of business and consumer spending, the amount of sales of Convenience TV's products, the competitive environment within the industry, the ability of Convenience TV to continue to expand its operations, the level of costs incurred in connection with Convenience TV's expansion efforts, economic conditions in the industry and the financial strength of Convenience TV's customers and suppliers. Convenience TV does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties.
President and CEO Norman Knowles states, "MediaRich is a good fit with their knowledge of the LA and national markets as well as their product placement and retail experience."
MediaRich Marketing works with television networks, syndicated television shows and digital networks to develop strategies to help generate revenue and drive sales. Convenience TV is a digital programming network which provides content in convenience stores based initially in the Los Angeles, California metro area with plans to extend to the top 20 advertising markets in the USA over the next several years.
MediaRich Marketing President Rick Thomas says, "The increase in digital signage in and around retail locations continues to grow quickly and The C Store Network is poised to provide convenience stores with content and sales related programs to help increase retail sales, which is much needed during this current economic environment. With brands looking for ways to extend their reach well beyond traditional methods of advertising, digital networks like C Store are perfect outlets to achieve those goals."
MediaRich Marketing has worked with ABC Television, Sum of the Best Productions, NASCAR Angels, Midas, CruisePoints.com and set up major product integration opportunities on game shows, talk shows and reality shows.
Safe Harbor Statement
Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to Convenience TV or its management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors such as the level of business and consumer spending, the amount of sales of Convenience TV's products, the competitive environment within the industry, the ability of Convenience TV to continue to expand its operations, the level of costs incurred in connection with Convenience TV's expansion efforts, economic conditions in the industry and the financial strength of Convenience TV's customers and suppliers. Convenience TV does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties.
Tuesday, September 7, 2010
Truesport Alliances & Entertainment, Ltd. Announces TapouT Training Center in Downtown Los Angeles, California
LAS VEGAS, Sept. 7, 2010 (GLOBE NEWSWIRE) -- Truesport Alliances & Entertainment, Ltd.'s (Pink Sheets:TSAN - News) TapouT Training Center will open at 400 West Pico Blvd, Los Angeles, CA 90015. The new training center is located in the heart of Los Angeles and is near the Staples Center, L.A. Live and the Los Angeles Convention Center.
As the fifth standalone of its kind, the TapouT Training Center is predominately a class based fitness facility with a full schedule that features a spectrum of MMA themed training. In addition to a broad selection of martial arts instruction, the majority of the cardio/fitness classes are non-contact.
"With the amazing location paired with the state-of-the-art mixed martial art equipment, this TapouT Training Center looks to be one of the most successful facilities we've opened yet," said Scott Ence, President of Truesport Alliances & Entertainment, Ltd.
"The Downtown Los Angeles TapouT Training Center will have the most elite trainers, the best equipment in the industry and will bring this area of Los Angeles a whole new level of MMA training," said Mark Kozlowski, owner of the new facility.
Amateur and professional fighters will have the opportunity to train with TapouT Certified Instructors. Classes or private sessions will be available with some of the world's most decorated instructors. Additionally, the TapouT Training Center will offer children's classes available for all ages.
The TapouT Training Center in Downtown Los Angeles will begin pre-sales of memberships immediately and will look to open its doors in mid-October.
For more information and for pre-sales, see www.tapoutworldwide.com or call 1-877-4-LA-TAPOUT 1-877-4-LA-TAPOUT or 1-877-452-8276 1-877-452-8276.
About Truesport Alliances & Entertainment, Ltd.
Truesport Alliances & Entertainment, Ltd. is the premier logistic marketer of branded concepts and equipment, partnering with the mixed martial arts (MMA) industry leaders. Embedded with the explosive growth MMA sport, the company's current clientele base includes the industry's top brands such as UFC, TapouT, Strikeforce and Gold's Gym. Visit the Truesport Alliances, Ltd. website at www.truesportltd.com
As the fifth standalone of its kind, the TapouT Training Center is predominately a class based fitness facility with a full schedule that features a spectrum of MMA themed training. In addition to a broad selection of martial arts instruction, the majority of the cardio/fitness classes are non-contact.
"With the amazing location paired with the state-of-the-art mixed martial art equipment, this TapouT Training Center looks to be one of the most successful facilities we've opened yet," said Scott Ence, President of Truesport Alliances & Entertainment, Ltd.
"The Downtown Los Angeles TapouT Training Center will have the most elite trainers, the best equipment in the industry and will bring this area of Los Angeles a whole new level of MMA training," said Mark Kozlowski, owner of the new facility.
Amateur and professional fighters will have the opportunity to train with TapouT Certified Instructors. Classes or private sessions will be available with some of the world's most decorated instructors. Additionally, the TapouT Training Center will offer children's classes available for all ages.
The TapouT Training Center in Downtown Los Angeles will begin pre-sales of memberships immediately and will look to open its doors in mid-October.
For more information and for pre-sales, see www.tapoutworldwide.com or call 1-877-4-LA-TAPOUT 1-877-4-LA-TAPOUT or 1-877-452-8276 1-877-452-8276.
About Truesport Alliances & Entertainment, Ltd.
Truesport Alliances & Entertainment, Ltd. is the premier logistic marketer of branded concepts and equipment, partnering with the mixed martial arts (MMA) industry leaders. Embedded with the explosive growth MMA sport, the company's current clientele base includes the industry's top brands such as UFC, TapouT, Strikeforce and Gold's Gym. Visit the Truesport Alliances, Ltd. website at www.truesportltd.com
mBeach Software Inc. Issues Stockholder Update
TEL AVIV, Israel, Sept. 7, 2010 (GLOBE NEWSWIRE) -- mBeach Software Inc. ("MBHS") (OTCBB:MBHS - News) today issued a stockholder update. The Company believes in the importance of regular communication and timely information delivered to investors. To this end, mBeach is committed to share with its stockholders release regular updates on its progress.
mBeach, through its wholly owned subsidiary Skin Cancer Scanning Ltd. ("SCS") is pioneering the development and commercialization of a revolutionary and proprietary diagnostic device for the early detection and diagnosis of skin cancer. Our product, an advanced stage prototype, SkinScan 650, is a non-invasive, point-of-care (in the doctor's office) system to detect and identify different kinds of skin nevi, tumors, lesions and cancers.
To date, we have successfully conducted two stages of clinical trials. The results from 128 scanned nevi demonstrated 92.4% accuracy in diagnosing non-melanoma skin cancer (NMSC). These results are significantly higher than the 75% accuracy achieved by an experienced dermatologist and 60% accuracy achieved by a general practitioner.
These initial results were gained by operating the device in the visual range (the light that we can see with an unaided eye) of the light spectrum.
We expect that further development of the devices' capabilities, into the Infra Red range, will dramatically improve results in diagnosing both Melanoma and Non Melanoma Skin Cancer.
We intend to complete the second stage development by July 2011. This will enable us to introduce into the market our SkinScan 650 diagnostic device with its full capabilities.
Our medical device, SkinScan 650's state-of-the-art technology will enable physicians to improve their diagnostic abilities using SkinScan 650. This will replace current diagnostic procedures that have many disadvantages, such as being relatively subjective and dependent on the experience of the examiner. Errors in diagnosis can be fatal. Cancers can remain undetected, grow further and lower chances of survival. A biopsy, the intrusive removal of tissue sample, is usually needed for further diagnoses.
For more information on SCS, visit the company's new website at www.scs-med.com.
Forward Looking Statements
This release contains forward-looking statements, including, but not limited to, statements regarding the future commercialization of SCS' products, the market demand for these products and the proprietary protections the Company will obtain with regard to the technology, all of which statements are subject to market risks, and the possibility that the Company will not be able to obtain patent protection or obtain sufficient customer demand. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties.
mBeach, through its wholly owned subsidiary Skin Cancer Scanning Ltd. ("SCS") is pioneering the development and commercialization of a revolutionary and proprietary diagnostic device for the early detection and diagnosis of skin cancer. Our product, an advanced stage prototype, SkinScan 650, is a non-invasive, point-of-care (in the doctor's office) system to detect and identify different kinds of skin nevi, tumors, lesions and cancers.
To date, we have successfully conducted two stages of clinical trials. The results from 128 scanned nevi demonstrated 92.4% accuracy in diagnosing non-melanoma skin cancer (NMSC). These results are significantly higher than the 75% accuracy achieved by an experienced dermatologist and 60% accuracy achieved by a general practitioner.
These initial results were gained by operating the device in the visual range (the light that we can see with an unaided eye) of the light spectrum.
We expect that further development of the devices' capabilities, into the Infra Red range, will dramatically improve results in diagnosing both Melanoma and Non Melanoma Skin Cancer.
We intend to complete the second stage development by July 2011. This will enable us to introduce into the market our SkinScan 650 diagnostic device with its full capabilities.
Our medical device, SkinScan 650's state-of-the-art technology will enable physicians to improve their diagnostic abilities using SkinScan 650. This will replace current diagnostic procedures that have many disadvantages, such as being relatively subjective and dependent on the experience of the examiner. Errors in diagnosis can be fatal. Cancers can remain undetected, grow further and lower chances of survival. A biopsy, the intrusive removal of tissue sample, is usually needed for further diagnoses.
For more information on SCS, visit the company's new website at www.scs-med.com.
Forward Looking Statements
This release contains forward-looking statements, including, but not limited to, statements regarding the future commercialization of SCS' products, the market demand for these products and the proprietary protections the Company will obtain with regard to the technology, all of which statements are subject to market risks, and the possibility that the Company will not be able to obtain patent protection or obtain sufficient customer demand. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties.
Convenience TV Signs With SeeSaw Networks
LOS ANGELES, CA--(Marketwire - 09/03/10) - Convenience TV Inc. (OTC.BB:CRPZ - News) is pleased to announce that it has signed an agreement with SeeSaw Networks to deliver ads for its C-Store Network installed in convenience stores.
Company President and CEO, Norman Knowles said, "It is extremely important to have a company like SeeSaw networks working on our behalf to bring revenue to our network. Being included as part of their network while we are building ours allows Convenience TV to be seen by national media buyers."
About Convenience TV Inc.
Convenience TV is focused on the Convenience Store Industry and provides their clients with an "in-location" TV network. The Network is designed to deliver both entertaining content and targeted advertising on a demographic basis to each retail location. In addition, the Network delivers promotional advertising tied to products within the retail location. The programming can be updated quickly and is tailored to meet the specific clients' need for increased sales, customer enjoyment and brand reinforcement.
About SeeSaw Networks
SeeSaw offers the most comprehensive digital place-based media solution in the marketplace. Through its national network, SeeSaw delivers advertising in places where people go in their daily lives -- such as gas stations, kids' gyms, coffee shops, grocery stores and health clubs. SeeSaw reaches more people in more places than any other digital placed-based video network, combining over 70 digital signage networks across over 40 different types of locations in over 50,000 venues nationally. SeeSaw's network delivers over 150 million weekly gross impressions, more than a primetime TV spot. SeeSaw's demand side platform, SeeSawAds.com, optimizes plans across geographies, venues, and demographics within budget constraints. SeeSaw's media specialists use SeeSawAds.com to customize campaigns with unprecedented precision and cost effectiveness. SeeSaw offers a variety of creative vehicles to advertisers, including ad spots, sponsorships of custom programming and content, brand integration, and experiential media, including sampling and activity integration. SeeSaw integrates research from Edison Research to close the loop and assess overall campaign effectiveness. With SeeSaw, advertisers can engage hard-to-reach people by intercepting them in their daily life patterns where they work play and socialize.
Safe Harbor Statement
Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to Convenience TV or its management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors such as the level of business and consumer spending, the amount of sales of Convenience TV's products, the competitive environment within the industry, the ability of Convenience TV to continue to expand its operations, the level of costs incurred in connection with Convenience TV's expansion efforts, economic conditions in the industry and the financial strength of Convenience TV's customers and suppliers. Convenience TV does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties.
Company President and CEO, Norman Knowles said, "It is extremely important to have a company like SeeSaw networks working on our behalf to bring revenue to our network. Being included as part of their network while we are building ours allows Convenience TV to be seen by national media buyers."
About Convenience TV Inc.
Convenience TV is focused on the Convenience Store Industry and provides their clients with an "in-location" TV network. The Network is designed to deliver both entertaining content and targeted advertising on a demographic basis to each retail location. In addition, the Network delivers promotional advertising tied to products within the retail location. The programming can be updated quickly and is tailored to meet the specific clients' need for increased sales, customer enjoyment and brand reinforcement.
About SeeSaw Networks
SeeSaw offers the most comprehensive digital place-based media solution in the marketplace. Through its national network, SeeSaw delivers advertising in places where people go in their daily lives -- such as gas stations, kids' gyms, coffee shops, grocery stores and health clubs. SeeSaw reaches more people in more places than any other digital placed-based video network, combining over 70 digital signage networks across over 40 different types of locations in over 50,000 venues nationally. SeeSaw's network delivers over 150 million weekly gross impressions, more than a primetime TV spot. SeeSaw's demand side platform, SeeSawAds.com, optimizes plans across geographies, venues, and demographics within budget constraints. SeeSaw's media specialists use SeeSawAds.com to customize campaigns with unprecedented precision and cost effectiveness. SeeSaw offers a variety of creative vehicles to advertisers, including ad spots, sponsorships of custom programming and content, brand integration, and experiential media, including sampling and activity integration. SeeSaw integrates research from Edison Research to close the loop and assess overall campaign effectiveness. With SeeSaw, advertisers can engage hard-to-reach people by intercepting them in their daily life patterns where they work play and socialize.
Safe Harbor Statement
Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to Convenience TV or its management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors such as the level of business and consumer spending, the amount of sales of Convenience TV's products, the competitive environment within the industry, the ability of Convenience TV to continue to expand its operations, the level of costs incurred in connection with Convenience TV's expansion efforts, economic conditions in the industry and the financial strength of Convenience TV's customers and suppliers. Convenience TV does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties.
Wednesday, September 1, 2010
Mammoth Energy Group Signs Second Letter of Intent to Acquire Lithium Concessions of Salt Gold Inter Chile Limitata of Chile
NEW YORK, NY--(Marketwire - 09/01/10) - Mammoth Energy Group Inc. (Pinksheets:MMTE - News) announced today that it has signed a Letter of Intent to acquire fifty-one (51%) of the outstanding stake of Salt Gold Inter Chile Limitada's concessions in the Salar de Maricunga located in the Atacama desert near Copiapo, Chile.
"We are very pleased to be finalizing our intentions with Salt Gold Inter Chile Limitada on the official signing of the Letter of intent to acquire Salt Gold Inter Chile's lithium concessions," announced William Lieberman, President of Mammoth Energy Group.
Salt Gold Inter Chile Limitada lithium concessions consist of 1008 acres in the Salar de Maricunga. Preliminary results of drilling and chemical analysis from its project under development has returned results and confirmed the presence of lithium -- potassium brine bearing aquifers. Brine Concentrations averaged grades of 650 ppm (parts per million) for lithium and 9500 ppm for potassium. These results confirm a significant third dimension to surface brines sampled on the project. The brine chemistry in the first test wells compares favorably to other Lithium companies in the region including the large multi-national Lithium producers whose estimates in the Atacama and throughout the region average 500 to 750 ppm Lithium and 9000-10000 ppm for potassium.
"Depths at the Salar de Maricunga average 100 Meters or 300 feet and currently acres are valued around $30,000 USD," said William Lieberman.
About Mammoth Energy Group Inc. (Pinksheets:MMTE - News) www.mammothenergygroup.com
Mammoth Energy Group Inc is focused on acquiring, developing and operating strategic mining energy reserves in locations throughout the world. With an ever changing shift to alternative energy and fuels Mammoth Energy Group will be prepared to be a leading energy supplier and operator. Mammoth Energy's goal is to become an important partner as the world's energy paradigm begins to change throughout the next decade and beyond.
Forward-Looking Statements
This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities and Exchange Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, and such Forward Looking Statements are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainties. All statements other than statements of historical fact in this announcement are forward-looking statements, including but not limited to the viability of the company's business plans, the effect of acquisitions on our profitability, the effectiveness, profitability, and the marketability of the Company's products; the Company's ability to protect its proprietary information; general economic and business conditions; the volatility of the company's operating results and financial condition; and other risks detailed in the Company's filings with the Securities and Exchange Commission.
These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations, assumptions, estimates and projections about the company and the industry. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or to changes in its expectations, except as may be required by law. Although the company believes that the expectations expressed in these forward-looking statements are reasonable, management cannot assure the public that their expectations will turn out to be correct, and investors are cautioned that actual results may differ materially from the anticipated results.
"We are very pleased to be finalizing our intentions with Salt Gold Inter Chile Limitada on the official signing of the Letter of intent to acquire Salt Gold Inter Chile's lithium concessions," announced William Lieberman, President of Mammoth Energy Group.
Salt Gold Inter Chile Limitada lithium concessions consist of 1008 acres in the Salar de Maricunga. Preliminary results of drilling and chemical analysis from its project under development has returned results and confirmed the presence of lithium -- potassium brine bearing aquifers. Brine Concentrations averaged grades of 650 ppm (parts per million) for lithium and 9500 ppm for potassium. These results confirm a significant third dimension to surface brines sampled on the project. The brine chemistry in the first test wells compares favorably to other Lithium companies in the region including the large multi-national Lithium producers whose estimates in the Atacama and throughout the region average 500 to 750 ppm Lithium and 9000-10000 ppm for potassium.
"Depths at the Salar de Maricunga average 100 Meters or 300 feet and currently acres are valued around $30,000 USD," said William Lieberman.
About Mammoth Energy Group Inc. (Pinksheets:MMTE - News) www.mammothenergygroup.com
Mammoth Energy Group Inc is focused on acquiring, developing and operating strategic mining energy reserves in locations throughout the world. With an ever changing shift to alternative energy and fuels Mammoth Energy Group will be prepared to be a leading energy supplier and operator. Mammoth Energy's goal is to become an important partner as the world's energy paradigm begins to change throughout the next decade and beyond.
Forward-Looking Statements
This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities and Exchange Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, and such Forward Looking Statements are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainties. All statements other than statements of historical fact in this announcement are forward-looking statements, including but not limited to the viability of the company's business plans, the effect of acquisitions on our profitability, the effectiveness, profitability, and the marketability of the Company's products; the Company's ability to protect its proprietary information; general economic and business conditions; the volatility of the company's operating results and financial condition; and other risks detailed in the Company's filings with the Securities and Exchange Commission.
These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations, assumptions, estimates and projections about the company and the industry. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or to changes in its expectations, except as may be required by law. Although the company believes that the expectations expressed in these forward-looking statements are reasonable, management cannot assure the public that their expectations will turn out to be correct, and investors are cautioned that actual results may differ materially from the anticipated results.
Subscribe to:
Posts (Atom)